Statements
databases
phosphosite
cbn
pc11
biopax
bel_lc
signor
biogrid
lincs_drug
tas
hprd
trrust
ctd
virhostnet
phosphoelm
drugbank
omnipath
|
rlimsp
isi
tees
geneways
eidos
trips
medscan
sparser
reach
reading
Lipopolysaccharide affects NFKBIA
1
|
4
196
1
2
|
24
65
Lipopolysaccharide affects RELA
2
|
89
Anthra[1,9-cd]pyrazol-6(2H)-one affects MAPK8
1
7
|
49
10
21
Tofacitinib affects JAK1
21
|
2
2
59
Reactive oxygen species affects NLRP3
|
66
Ruxolitinib affects JAK1
1
13
|
2
47
Nitric oxide affects NLRP3
|
58
Bortezomib affects NFKBIA
|
1
1
41
Lipopolysaccharide affects NLRP3
|
42
Anthra[1,9-cd]pyrazol-6(2H)-one affects JUN
|
12
4
26
Lipopolysaccharide affects IFNB1
|
1
35
Lipopolysaccharide affects NFKB1
|
31
Lipopolysaccharide affects CASP1
|
1
1
1
28
Doramapimod affects MAPK14
1
28
|
Nitric oxide affects CASP1
|
1
26
Resveratrol affects NLRP3
|
26
Reactive oxygen species affects CASP1
|
2
22
Acetylsalicylic acid affects IKBKB
4
|
1
4
15
(-)-epigallocatechin 3-gallate affects STAT1
1
|
1
22
3',5'-cyclic AMP affects NLRP3
|
24
Potassium(1+) affects NLRP3
|
22
Lipopolysaccharide affects STAT1
|
22
Bortezomib affects RELA
4
|
1
17
Tofacitinib citrate affects JAK1
21
|
TASOCITINIB affects JAK1
21
|
5Z-7-oxozeaenol affects MAP3K7
5
|
16
Tofacitinib affects TYK2
16
|
4
Sulforaphane affects NLRP3
|
20
P-menthan-3-ol affects ITCH
|
9
11
N-[3-[[5-iodo-4-[3-[[oxo(thiophen-2-yl)methyl]amino]propylamino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide affects TBK1
1
1
|
18
Salicylic acid affects IKBKB
|
19
Oroxylin A(1-) affects NLRP3
|
19
2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1-pyrazolyl]-3-azetidinyl]acetonitrile affects JAK1
5
|
14
Phenethyl caffeate affects NLRP3
|
1
17
(-)-epigallocatechin 3-gallate affects DDX58
|
1
17
Resveratrol affects RELA
12
|
5
Minocycline affects CASP1
2
|
3
12
Lipopolysaccharide affects IRF3
|
17
(-)-epigallocatechin 3-gallate affects JUN
|
1
2
14
Tofacitinib citrate affects TYK2
16
|
Sulfonylurea affects NLRP3
|
16
Methylene blue affects NLRP3
|
1
15
TASOCITINIB affects TYK2
16
|
(R)-lipoic acid affects IKBKB
|
6
10
(-)-epigallocatechin 3-gallate affects RELA
|
4
12
Nitric oxide affects MAPK8
|
3
12
4
|
2
9
|
1
13
Scutellarin(1-) affects NLRP3
|
13
Ruxolitinib affects TYK2
10
|
3
Ruxolitinib phosphate affects JAK1
13
|
Parthenolide affects CASP1
|
4
9
S-Ruxolitinib affects JAK1
13
|
3',5'-cyclic AMP affects JUN
|
13
Nitric oxide affects RELA
|
12
Lipopolysaccharide affects TRAF6
|
12
Calcium(2+) affects NLRP3
|
12
3-hydroxybutyric acid affects NLRP3
|
3
9
(-)-epigallocatechin 3-gallate affects ITCH
|
12
Parthenolide affects RELA
3
|
9
Staurosporine affects IKBKB
8
|
3
Sodium(1+) affects NFKB1
|
11
Salicylic acid affects NFKB1
|
11
Salicylate affects IKBKB
|
11
Resveratrol affects JUN
|
11
Methylene blue affects CASP1
|
11
Lipopolysaccharide affects JUN
|
11
Hydroxychloroquine affects NLRP3
|
11
Carbon monoxide affects NLRP3
|
11
Butyric acid affects STAT1
1
|
3
7
Ruxolitinib phosphate affects TYK2
10
|
|
10
Parthenolide affects NLRP3
|
2
8
Morphine(1+) affects FOS
|
10
Isotretinoin affects JUN
|
10
Fenofibrate affects RELA
2
|
8
Butyric acid affects NLRP3
|
10
Bortezomib affects NFKB1
2
|
8
[11C]-SORAFENIB affects MAPK14
10
|
S-Ruxolitinib affects TYK2
10
|
Lipopolysaccharide affects TICAM1
|
10
Tofacitinib affects STAT1
|
9
Sodium(1+) affects IKBKB
|
9
Pyruvic acid affects RELA
|
9
Nitric oxide affects NFKB1
|
9
Dihydroartemisinin affects NLRP3
|
1
8
Chloroquine affects ITCH
|
9
Arachidonic acid affects NLRP3
|
9
N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide affects RIPK1
3
|
2
4
Withaferin A affects IKBKG
|
5
3
Resveratrol affects MAPK8
2
|
5
1
Quercetagetin affects MAPK8
|
1
1
6
Pyruvic acid affects NLRP3
|
8
Prostaglandin E2-UM affects NLRP3
|
1
7
Phenethyl caffeate affects RELA
1
|
2
5
Phenethyl caffeate affects CASP1
|
8
Parthenolide affects IKBKB
|
3
5
Naltrexone affects ITCH
|
8
Lithium(1+) affects JUN
|
2
6
Doxorubicin affects NFKBIA
|
8
Dasatinib (anhydrous) affects MAPK14
8
|
Cyclosporin A affects RELA
|
8
Chloroquine affects IFNB1
|
8
Azithromycin affects NLRP3
|
8
Atorvastatin affects NLRP3
|
8
Oclacitinib affects JAK1
2
|
6
|
1
1
6
Wedelolactone affects IKBKB
1
|
2
3
1
Wedelolactone affects CHUK
|
1
4
2
Tacrolimus (anhydrous) affects NFKB1
|
7
Staurosporine affects MAPK8
7
|
Simvastatin affects STAT1
1
|
6
Resveratrol affects TICAM1
|
7
Reactive oxygen species affects RELA
|
7
Potassium(1+) affects CASP1
|
1
6
Phorbol 13-acetate 12-myristate affects JUN
|
1
6
Okadaic acid affects NFKBIA
|
7
Morphine(1+) affects RELA
|
1
6
Dihydrogen affects NLRP3
|
7
Cycloheximide affects NFKBIA
|
7
Butorphanol affects ITCH
|
7
Bortezomib affects TRAF6
|
7
All-trans-retinoic acid affects JUN
|
7
Acetylsalicylic acid affects NFKB1
|
7
3
|
4
N-[3-[[5-cyclopropyl-2-[3-(4-morpholinylmethyl)anilino]-4-pyrimidinyl]amino]propyl]cyclobutanecarboxamide affects TBK1
1
|
6
(-)-epigallocatechin 3-gallate affects TRAF6
|
3
4
Antagonist affects ITCH
|
7
Thiostrepton affects RELA
|
6
Sulforaphane affects RELA
|
6
Staurosporine affects JAK1
5
|
1
Sodium(1+) affects NLRP3
|
6
Simvastatin affects NLRP3
|
6
Simvastatin affects IFNB1
|
6
Pyridoxamine affects NLRP3
|
6
Phenethyl caffeate affects PYCARD
|
6
Momelotinib affects JAK1
1
2
|
3
Mevalonic acid affects NFKBIA
|
6
Mesalamine affects RELA
|
2
4
Magnesium atom affects RELA
|
6
Lipopolysaccharide affects TRAF3
|
6
Lipopolysaccharide affects FOS
|
6
Kaempferol oxoanion affects STAT1
|
6
Glutathione affects JUN
|
1
5
Gamma-aminobutyric acid affects ITCH
|
6
Gallic acid affects RELA
|
6
Calcitriol affects RELA
1
|
5
Acetic acid affects NLRP3
|
6
Filgotinib affects JAK1
4
|
2
Acetylsalicylic acid affects IKBKB
6
|
5z-7-oxozeaenol affects MAP3K7
5
|
1
|
6
|
3
3
Withaferin A affects NLRP3
|
1
4
Vorinostat affects NFKB1
2
|
3
Troglitazone affects FOS
|
5
Trichostatin A affects RELA
2
|
3
Ticagrelor affects NLRP3
|
5
Sitosterol affects DDX58
|
1
4
Retinoic acid affects FOS
|
5
Resveratrol affects MYD88
1
|
4
Resveratrol affects MAP3K7
|
5
Quinacrine affects RELA
|
5
Pyrrolidine affects NFKB1
|
5
Pyrrolidine dithiocarbamate affects RELA
4
|
1
Pyrimidine affects DDX58
|
5
Pseudouridine affects DDX58
|
5
Phenethyl caffeate affects NFKBIA
|
5
Palbociclib affects JUN
|
3
2
Nitric oxide affects JUN
|
1
4
Morphine(1+) affects ITCH
|
5
Minocycline affects NLRP3
|
5
Lithium(1+) affects STAT1
|
5
Lithium(1+) affects NFKB1
|
5
Liraglutide affects NLRP3
|
5
Lipopolysaccharide affects MAP3K7
|
5
Lipopolysaccharide affects IKBKB
|
5
Lipopolysaccharide affects CHUK
|
5
Hexadecanoic acid affects NFKBIA
|
5
Dimethyl sulfide affects NLRP3
|
5
Dapagliflozin affects NLRP3
|
5
Cyclosporin A affects ITCH
|
5
Calcium(2+) affects NFKBIA
|
5
Calcium(2+) affects FOS
|
5
Calcium(2+) affects CASP1
|
1
4
Barium(2+) affects NFKBIA
|
5
Acetylsalicylic acid affects NFKBIA
|
1
4
Acetylsalicylic acid affects JUN
|
3
2
SUNITINIB MALATE affects JAK1
5
|
N-methyl-D-aspartic acid affects FOS
|
5
N-acetyl-L-cysteine affects NLRP3
|
5
N-acetyl-L-cysteine affects NFKB1
2
|
3
N-acetyl-L-cysteine affects JUN
2
|
3
N-[3-[[5-iodo-4-[3-[[oxo(thiophen-2-yl)methyl]amino]propylamino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide affects IKBKE
1
1
|
3
N-[3-[[5-iodo-4-[3-[[oxo(thiophen-2-yl)methyl]amino]propylamino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide affects IFNB1
|
5
N-[3-[[5-cyclopropyl-2-[3-(4-morpholinylmethyl)anilino]-4-pyrimidinyl]amino]propyl]cyclobutanecarboxamide affects IKBKE
1
|
4
Ac-Asp-Glu-Val-Asp-H affects CASP1
1
|
4
5E-7-oxozeaenol affects MAP3K7
5
|
|
5
2-aminoethoxydiphenylborane affects NLRP3
|
5
|
2
1
2
5
|
(R)-lipoic acid affects RELA
|
5
3',5'-cyclic AMP affects NFKB1
|
5
Glucocorticoid affects JUN
|
3
2
Gallic acid affects STAT1
|
5
Lipopolysaccharide affects MYD88
|
5
Withaferin A affects IKBKB
|
3
1
Vorinostat affects RELA
2
|
2
Vigabatrin affects TRIM25
|
4
Vancomycin(1+) affects MAVS
|
4
Trichostatin A affects IFNB1
|
4
Trans-piceid affects NLRP3
|
4
Topiramate affects STAT1
|
4
Tofacitinib affects ITCH
|
4
Tetrodotoxin affects FOS
|
4
Temozolomide affects NFKB1
|
1
3
Tacrolimus (anhydrous) affects NFKBIA
|
4
Sulforaphane affects CASP1
|
4
Staurosporine affects TYK2
4
|
Sodium(1+) affects ITCH
|
4
Silicon dioxide affects MYD88
|
4
Sevoflurane affects JUN
|
4
Rosiglitazone affects RELA
|
1
3
Retinoic acid affects CASP1
|
4
Resveratrol affects TBK1
|
4
Resveratrol affects CASP1
2
|
2
Reactive oxygen species affects NFKBIA
|
4
Reactive oxygen species affects NFKB1
|
4
Pyruvic acid affects NFKB1
|
4
Progesterone affects RELA
1
|
3
Potassium chloride affects NLRP3
|
4
Phorbol 13-acetate 12-myristate affects FOS
|
4
Phenethyl caffeate affects FOS
|
4
Phenazine-1-carboxylate affects RELA
|
2
2
Parthenolide affects NFKBIA
|
4
Paracetamol affects IFNB1
|
4
Paclitaxel affects NFKBIA
|
4
Olmesartan affects MAP3K7
|
4
Oligonucleotide affects RELA
|
4
Nitric oxide affects NFKBIA
|
1
3
Nitric oxide affects EIF2AK1
1
|
3
Nedocromil affects ITCH
|
4
Morphine(1+) affects TRAF6
|
1
3
Mangiferin affects NLRP3
|
4
Lithium chloride affects RELA
|
4
Lithium chloride affects IFNB1
|
4
Lansoprazole affects IRF7
|
1
3
Isotretinoin affects FOS
2
|
2
Isoflurane affects RELA
|
4
Imipramine affects FOS
|
4
Hydroxychloroquine affects TLR7
|
4
Glutathione affects PYCARD
|
4
Glutathione affects NFKB1
|
4
Glutathione affects MAPK8
|
4
Gallic acid affects RIPK1
|
4
Fenfluramine affects FOS
|
4
Double-stranded RNA affects IRF3
|
4
Double-stranded RNA affects DDX58
|
4
Dihydroartemisinin affects RELA
|
2
2
Dihydroartemisinin affects NFKBIA
|
4
Dihydroartemisinin affects NFKB1
|
4
Diarsenic trioxide affects RELA
4
|
Dexamethasone affects RELA
1
|
3
Cis-doxepin affects ITCH
|
4
Cholesterol affects NLRP3
|
4
Chloroquine affects STING1
|
4
Carbon monoxide affects RELA
|
4
Brefeldin A affects STING1
|
4
Betulinic acid affects JAK1
|
4
Benzyl isothiocyanate affects RELA
|
4
Arsenite(3-) affects IKBKB
1
|
3
Arsenite(3-) affects FOS
|
4
Acetic acid affects MYD88
|
4
SUNITINIB MALATE affects TYK2
4
|
SUNITINIB MALATE affects IKBKE
4
|
PCID:76516568 affects MAPK8
|
4
|
1
3
N-acetyl-L-cysteine affects MAPK14
|
4
Minocycline affects CASP1
4
|
L-prolylglycine affects MYD88
|
4
Interferon alfacon-1 affects IFNAR1
4
|
Interferon alfa-2b affects IFNAR2
4
|
Interferon alfa-2b affects IFNAR1
4
|
Human interferon beta affects IFNAR1
4
|
FILGOTINIB affects JAK1
4
|
FILGOTINIB HYDROCHLORIDE affects JAK1
4
|
Acetylsalicylic acid affects CASP1
4
|
AICA ribonucleotide affects STAT1
|
4
|
4
1
1
|
2
5Z-7-Oxozeaenol affects MAP3K7
|
4
|
4
|
1
3
|
4
24,25-Dihydroxyvitamin D affects NLRP3
|
4
24,25-Dihydroxyvitamin D affects NFKBIA
|
4
24,25-Dihydroxyvitamin D affects IFNB1
|
4
2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1-pyrazolyl]-3-azetidinyl]acetonitrile affects TYK2
4
|
2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile affects TRIM25
|
4
|
2
1
1
|
1
3
|
4
(-)-epigallocatechin 3-gallate affects IKBKB
|
4
(-)-epigallocatechin 3-gallate affects FOS
1
|
3
(-)-epigallocatechin 3-gallate affects CASP1
|
4
(+)-artemisinin affects RELA
|
4
(+)-abscisic acid affects PYCARD
|
4
Ruxolitinib affects STAT1
|
4
Sulfasalazine affects IKBKB
2
|
2
Sulfasalazine affects CHUK
2
|
2
Adenosine 5'-monophosphate affects NLRP3
|
4
Trichostatin A affects NFKBIA
|
1
2
Trichostatin A affects MYD88
|
3
Tofacitinib affects RELA
|
3
Tetracycline affects CASP1
|
3
Testosterone affects STAT1
|
3
Temozolomide affects RELA
1
|
2
Superoxide affects CASP1
|
1
1
1
Sumatriptan affects ITCH
|
1
2
Sulfasalazine affects RELA
3
|
Strontium(2+) affects ITCH
|
3
Staurosporine affects NFKBIA
|
3
Staurosporine affects JUN
|
3
Staurosporine affects IKBKE
3
|
Staurosporine affects CHUK
3
|
Sodium(1+) affects RELA
|
3
Sodium atom affects NLRP3
|
3
Sevoflurane affects NLRP3
|
3
Selenium atom affects RELA
1
|
2
Selenium atom affects NLRP3
|
3
Salicylic acid affects RELA
|
3
Salicylic acid affects NLRP3
|
3
Resveratrol affects NFKBIA
1
|
2
Resveratrol affects NFKB1
2
|
1
Reactive oxygen species affects MAVS
|
3
Reactive oxygen species affects JUN
|
3
Quetiapine affects RELA
|
3
Pyrrole-2-carboxylic acid affects JUN
|
3
Prostaglandin E2 affects NLRP3
|
3
Pregabalin affects ITCH
|
3
Polyinosinic-polycytidylic acid affects IRF3
|
3
Phenethyl caffeate affects NFKB1
1
|
2
Okadaic acid affects ITCH
|
1
2
Nitric oxide affects STAT1
|
3
Nitric oxide affects FOS
|
3
Nickel(2+) affects IRF7
|
3
Mycophenolate mofetil affects ITCH
|
3
Morphine(1+) affects DDX58
|
3
Mirtazapine affects ITCH
|
3
Minocycline affects NFKBIA
|
3
Minocycline affects JUN
1
|
1
1
Midostaurin affects TYK2
3
|
Midostaurin affects JAK1
3
|
Midostaurin affects IKBKE
3
|
Midostaurin affects FOS
|
3
Methotrexate affects NLRP3
|
3
Mefenamic acid affects NLRP3
|
3
Magnesium(2+) affects NLRP3
|
3
Lipopolysaccharide affects MAPK14
1
|
2
Kaempferol oxoanion affects NFKB1
|
3
Isoliquiritigenin(1-) affects NLRP3
|
1
2
Indole-3-methanol affects RELA
3
|
Hydroxychloroquine affects CASP1
|
3
Hydrogen sulfide affects NLRP3
|
3
Hydrogen peroxide affects MAPK14
|
3
Homocysteine affects NLRP3
|
3
Hexadecanoic acid affects MYD88
|
3
Haloperidol affects FOS
|
3
Glycine betaine affects NLRP3
|
3
Geldanamycin affects IRF3
|
1
2
Gallic acid affects IFNB1
|
3
Gabapentin affects ITCH
|
3
Formic acid affects NLRP3
|
3
Fexofenadine affects ITCH
|
3
Febuxostat affects NLRP3
|
3
Ethidium bromide affects CASP1
|
3
Endomorphin-2 affects FOS
|
3
Doxycycline affects NFKB1
|
3
Doxorubicin affects RELA
|
3
Doxorubicin affects IFNB1
|
3
Double-stranded RNA affects OAS1
|
3
Dorsomorphin affects NLRP3
|
3
Dimethyl sulfoxide affects NLRP3
|
3
Dihydrogen affects RELA
|
3
Dihydroartemisinin affects MYD88
|
3
Dihydroartemisinin affects CHUK
|
3
Dexmedetomidine affects NLRP3
|
3
Dexamethasone affects NFKBIA
|
3
Dexamethasone affects NFKB1
|
3
Dexamethasone affects FOS
|
3
Cyclosporin A affects NLRP3
|
3
Coenzyme Q10 affects NLRP3
|
3
Chrysophanol affects NLRP3
|
3
Chondroitin sulfate affects CASP1
|
3
Cetirizine affects ITCH
|
3
Carboplatin affects RELA
1
|
2
Carbamazepine affects FOS
|
3
Calcium(2+) affects STAT1
|
3
Cadmium atom affects NFKBIA
|
3
Bumetanide affects ITCH
|
3
Bilirubin IXalpha affects IFNB1
|
3
Beta-lapachone affects NFKBIA
|
3
Beta-D-glucose affects NFKBIA
|
3
Azithromycin affects TLR7
|
3
Atorvastatin affects RELA
|
3
Arsenite(3-) affects EIF2AK1
|
3
Arachidonic acid affects IKBKB
|
3
Anthra[1,9-cd]pyrazol-6(2H)-one affects RELA
|
3
Anthra[1,9-cd]pyrazol-6(2H)-one affects IRF3
|
1
2
Amitriptyline affects CASP1
|
3
All-trans-retinoic acid affects RELA
|
3
Acetylcholine affects STAT1
|
3
Acetoacetate affects NLRP3
|
3
TOZASERTIB LACTATE affects TYK2
3
|
TOZASERTIB LACTATE affects RIPK1
3
|
SUNITINIB MALATE affects TBK1
3
|
SUNITINIB MALATE affects RIPK1
3
|
SUNITINIB MALATE affects CHUK
3
|
PRALNACASAN affects CASP1
3
|
PCID:5353940 affects MAPK14
|
3
Oclacitinib affects TYK2
2
|
1
N-acetyl-L-cysteine affects RELA
2
|
1
N-acetyl-L-cysteine affects MAPK8
|
3
N-acetyl-L-cysteine affects FOS
2
|
1
N-acetyl-L-cysteine affects CASP1
|
3
N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide affects TYK2
3
|
N-[3-[[5-iodo-4-[3-[[oxo(thiophen-2-yl)methyl]amino]propylamino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide affects IRF3
|
3
Mesalazine affects IKBKB
3
|
Mesalazine affects CHUK
3
|
LPS with O-antigen affects RELA
|
3
L-ascorbic acid affects NFKBIA
|
3
L-ascorbic acid affects IKBKB
|
3
Interferon alfacon-1 affects IFNAR2
3
|
Inhibitor of P38 Kinase affects MAPK14
3
|
Filgotinib affects TYK2
3
|
FLAVOPYRIDOL affects TYK2
3
|
FILGOTINIB affects TYK2
3
|
FILGOTINIB HYDROCHLORIDE affects TYK2
3
|
D-cycloserine affects NFKBIA
|
1
2
Aminosalicylic acid affects CHUK
3
|
AICA ribonucleotide affects NLRP3
|
3
6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one affects MAPK8
3
|
6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one affects CASP1
|
3
5-(5,6-dimethoxy-1-benzimidazolyl)-3-[(2-methylsulfonylphenyl)methoxy]-2-thiophenecarbonitrile affects IKBKE
3
|
4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-quinolinone affects TYK2
3
|
4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-quinolinone affects IKBKE
3
|
4-[[5-amino-1-[(2,6-difluorophenyl)-oxomethyl]-1,2,4-triazol-3-yl]amino]benzenesulfonamide affects JAK1
3
|
|
3
4-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[(5-nitro-2-thiazolyl)thio]-1H-1,2,4-triazol-5-one affects MAPK8
1
2
|
|
3
|
3
3-(Benzyloxy)Pyridin-2-Amine affects MAPK14
3
|
24,25-Dihydroxyvitamin D affects RELA
|
3
24,25-Dihydroxyvitamin D affects NFKB1
|
3
2-thiouridine affects TLR7
|
1
2
2-thiouridine affects DDX58
|
1
2
|
2
1
2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1-pyrazolyl]-3-azetidinyl]acetonitrile affects ITCH
|
3
1H-imidazole affects MAPK14
|
3
1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One affects MAPK14
3
|
1,4-benzoquinone affects CASP1
1
|
2
(S)-naringenin affects IFNB1
|
3
(E)-3-tosylacrylonitrile affects NLRP3
|
3
(-)-epigallocatechin 3-gallate affects IRF3
|
3
(+)-artemisinin affects NFKB1
|
3
N-[(3Z)-5-Tert-butyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-ylidene]-N'-(4-chlorophenyl)urea affects MAPK14
3
|
3
|
3',5'-cyclic AMP affects NFKBIA
|
3
Oligonucleotide affects TLR7
|
2
1
Ginsenoside Rb1 affects RELA
|
3
5'-S-methyl-5'-thioadenosine affects STAT1
|
1
2
Wedelolactone affects NFKBIA
1
|
1
Valproic acid affects RELA
|
2
Valproic acid affects NFKBIA
|
2
Valproic acid affects FOS
|
2
Ursolic acid affects CHUK
|
2
Ursodeoxycholic acid affects ITCH
|
2
Troglitazone affects RELA
2
|
Triazolopyridine affects MAPK14
2
|
Trans-anethole affects NFKBIA
|
2
Trans-aconitic acid affects CASP1
|
2
Theophylline affects NFKB1
|
2
Theophylline affects IRF7
|
2
Theaflavin affects NFKBIA
|
2
Thapsigargin affects NLRP3
|
2
Tetramethylpyrazine affects MAPK14
|
2
Tetracycline affects RELA
|
2
Testosterone affects NFKB1
|
2
Tert-butyl hydroperoxide affects ITCH
|
2
Temozolomide affects NFKBIA
|
2
Technetium atom affects RELA
|
2
Tanespimycin affects RIPK1
|
2
Tanespimycin affects IRF3
|
2
Tanespimycin affects IKBKB
|
2
Talmapimod affects MAPK14
2
|
Tacrolimus (anhydrous) affects RELA
|
2
Tacrolimus (anhydrous) affects MAPK8
1
|
1
Superoxide affects NFKBIA
|
2
Sulindac sulfide affects RELA
2
|
Sulforaphane affects PYCARD
|
2
Sulforaphane affects MYD88
|
1
1
Sulforaphane affects JUN
|
2
Sulfasalazine affects NFKB1
|
2
Streptomycin(3+) affects TRIM25
|
2
Staurosporine affects TBK1
2
|
Staurosporine affects MAP3K7
2
|
Staurosporine affects FOS
|
2
Sodium(1+) affects JUN
|
2
Sodium chloride affects PYCARD
|
2
Sodium atom affects RELA
|
2
Sodium atom affects PYCARD
|
2
Sodium atom affects JAK1
|
1
1
Sodium atom affects CASP1
|
2
Sodium arsenite affects RELA
2
|
Simvastatin affects RIPK1
|
2
Simvastatin affects RELA
|
2
Simvastatin affects CASP1
1
|
1
Silver(1+) affects STAT1
|
2
Silver(1+) affects FOS
|
2
Silicon dioxide affects NFKBIA
|
2
Selenium atom affects NFKBIA
|
2
Seaborgium atom affects TICAM1
|
2
Seaborgium atom affects IFNB1
|
2
Scutellarin(1-) affects CASP1
|
2
Salicylic acid affects NFKBIA
|
2
Salicylic acid affects CHUK
|
2
Salicylate affects NLRP3
|
2
Salicylate affects NFKBIA
|
2
Retinoic acid affects PYCARD
|
1
1
Resveratrol affects TRAF6
|
2
Resveratrol affects STAT1
|
1
1
Resveratrol affects JAK1
|
2
Resiquimod affects TLR7
1
|
1
Regorafenib affects FOS
|
2
Reactive oxygen species affects TRAF6
|
2
Reactive oxygen species affects RIPK1
|
2
Reactive oxygen species affects IFNB1
|
2
Reactive oxygen species affects FOS
|
2
Quetiapine affects NFKB1
|
2
Pyrrolidine dithiocarbamate affects NFKB1
2
|
Pyrimidine affects JAK1
|
2
Pyrimethamine affects RELA
|
2
Pyridoxamine affects CASP1
|
2
Pterostilbene affects NLRP3
|
2
Psoralidin affects RELA
|
2
Pseudouridine affects TLR7
|
1
1
Prostaglandins affects CASP1
|
2
Prostaglandin I2 affects STAT1
|
2
Prostaglandin E2-UM affects CASP1
|
2
Prostaglandin E1 affects RELA
|
2
Progesterone affects MYD88
|
2
Probenecid affects NLRP3
|
2
Probenecid affects CASP1
|
2
Pregnenolone affects TRAF6
|
2
Pramocaine affects ITCH
|
2
Potassium chloride affects CASP1
|
2
Poly(cytidylic acid) affects NFKBIA
|
2
Pioglitazone affects RELA
|
2
Piceatannol affects STAT1
|
2
Piceatannol affects MYD88
|
2
Piceatannol affects MAPK8
|
2
Piceatannol affects JAK1
|
2
Phosphatidic acid affects NLRP3
|
2
Phosphatidic acid affects NFKBIA
|
2
Phorbol 13-acetate 12-myristate affects RELA
1
|
1
Phenylmethanesulfonyl fluoride affects RELA
|
2
Phenylephrine affects NLRP3
|
2
Phenyl isocyanate affects IFNB1
|
2
Phenethyl caffeate affects IRF3
|
2
Pevonedistat affects NFKBIA
|
1
1
Pevonedistat affects IFNB1
|
2
Pentobarbital affects JUN
2
|
Pazopanib hydrochloride affects RIPK1
2
|
Parthenolide affects PYCARD
|
2
Parthenolide affects MYD88
|
2
Parthenolide affects CHUK
|
2
Paricalcitol affects TRAF3
|
1
1
Panobinostat affects NFKB1
|
2
Palmitoyl ethanolamide affects ITCH
|
2
Oseltamivir affects NLRP3
|
2
Oligonucleotide affects STAT1
|
2
Nordihydroguaiaretic acid affects STAT1
|
2
Nordihydroguaiaretic acid affects JUN
1
|
1
|
2
Nocodazole affects STAT1
|
2
Nitric oxide affects STING1
|
2
Nitric oxide affects RIPK1
|
2
Nitric oxide affects IKBKB
|
1
1
Nifedipine affects JUN
|
2
Nicotinic acid affects NLRP3
|
2
Nicotinamide affects CASP1
|
2
Nicorandil affects CASP1
|
2
Nickel(2+) affects IRF3
|
2
Nevirapine affects IFNB1
|
2
Nalbuphine affects ITCH
|
2
Morphine(1+) affects JUN
|
2
Minocycline affects ITCH
|
2
Minocycline affects IFNB1
|
2
Midostaurin affects TBK1
2
|
Midostaurin affects MAP3K7
2
|
Masoprocol affects JUN
1
|
1
Mangiferin affects RELA
|
2
Malonaldehyde affects TLR7
|
2
MTOR inhibitor affects RELA
|
2
Luteolin 7-O-beta-D-glucoside affects CASP1
|
2
Lithium(1+) affects TBK1
|
2
Lithium(1+) affects IFNB1
|
2
Lipoxin A4 affects TRAF6
|
2
Lipopolysaccharide affects PYCARD
|
2
Lipopolysaccharide affects ITCH
|
2
Levamisole affects IFNB1
|
2
Leptomycin B affects STAT1
|
1
1
Kaempferol affects NLRP3
|
2
Kaempferol oxoanion affects TYK2
|
2
Isotretinoin affects RELA
2
|
Isotretinoin affects NFKB1
2
|
Isoflurane affects NLRP3
|
2
Isoflavone affects RELA
|
2
Isocyanic acid affects JUN
|
2
Indole-3-methanol affects NFKB1
2
|
Hydroxychloroquine affects STING1
|
2
Hydrogen peroxide affects NFKBIA
|
1
1
Hydrogen peroxide affects NFKB1
|
1
1
Hydrogen chloride affects NLRP3
|
2
Hyaluronic acid affects MAPK14
|
2
Homocysteine affects CASP1
|
2
Hexadecanoic acid affects TICAM1
|
2
Hexadecanoic acid affects NLRP3
|
2
Hexadecanoic acid affects CASP1
|
2
Hexadecane affects PYCARD
|
2
Hexadecane affects ITCH
|
2
Herbimycin affects STAT1
1
|
1
Glutathione affects RELA
|
2
Glutathione affects NFKBIA
|
2
Glutathione affects JAK1
|
2
Glucocorticoid affects TBK1
|
2
Ginsenoside Rb1 affects NFKBIA
|
2
Ginsenoside Rb1 affects IKBKB
|
2
Ganetespib affects RIPK1
|
2
Gallic acid affects JAK1
|
2
Gallic acid affects IKBKB
|
2
Gallic acid affects CHUK
1
|
1
Furosemide affects ITCH
|
2
Formononetin affects NLRP3
|
2
Flufenamic acid affects NLRP3
|
2
Fingolimod hydrochloride affects PYCARD
|
2
Fingolimod hydrochloride affects NLRP3
|
2
Fenofibrate affects NFKB1
|
2
Ethyl methanesulfonate affects RELA
|
2
Ethyl methanesulfonate affects PYCARD
|
2
Ent-crizotinib affects IKBKE
2
|
Empagliflozin affects NLRP3
|
2
Ellagic acid affects JUN
|
2
Ecgonine benzoate affects NFKBIA
|
2
Ecgonine benzoate affects CASP1
|
2
Doxycycline affects MAP3K7
|
2
Doxorubicin affects IKBKB
|
2
Doxorubicin affects CHUK
|
2
Double-stranded RNA affects IFIH1
|
2
Doramapimod affects MAP3K7
2
|
Disulfiram affects NLRP3
|
2
Disulfiram affects NFKB1
1
|
1
Disodium selenite affects MAPK8
1
|
1
Disodium selenite affects JUN
2
|
Dihydrogenvanadate affects NFKBIA
|
2
Dihydroartemisinin affects FOS
|
2
Dihydroartemisinin affects CASP1
|
2
Diclofenac affects NFKBIA
|
2
Dexmedetomidine affects RELA
|
2
Dexamethasone affects MAPK14
1
|
1
Dexamethasone affects JUN
|
2
Dexamethasone affects IFNB1
|
2
Desmopressin affects RELA
|
2
Desferrioxamine B affects NFKBIA
|
2
Daunorubicin(1+) affects RELA
|
2
Cyclosporin A affects STAT1
|
2
Cyclosporin A affects NFKB1
|
2
Cyclosporin A affects IRF9
|
2
Cycloheximide affects STAT1
|
1
1
Cycloheximide affects NLRP3
|
2
Cucurbitacin B affects RELA
|
2
Crotamiton affects ITCH
|
2
Crizotinib affects IKBKE
2
|
Corticosterone affects FOS
|
1
1
Copper(2+) affects JUN
|
1
1
Concanamycin A affects TLR7
|
2
Colchicine affects NLRP3
|
2
Colchicine affects CASP1
|
1
1
Cimetidine affects FOS
|
2
Cilostazol affects RELA
|
2
Cidofovir anhydrous affects STAT2
|
1
1
Chondroitin affects NFKB1
|
2
Cholesterol affects TBK1
|
2
Cholesterol affects STING1
|
2
Chloroquine affects NFKBIA
|
1
1
Chloroquine affects MYD88
|
2
Ceruletide affects NFKBIA
|
2
Ceruletide affects IFNAR1
|
2
Carbon monoxide affects EIF2AK1
|
2
Carbon monoxide affects CASP1
|
2
Calcium(2+) affects NFKB1
|
2
Calcitriol affects STAT1
|
2
Cadmium(2+) affects JUN
|
2
Cadmium dichloride affects RELA
1
|
1
Cadmium atom affects PYCARD
|
2
Cadmium atom affects JUN
|
2
Butyric acid affects RELA
|
2
Butyric acid affects NFKBIA
|
2
Butyric acid affects CASP1
|
2
Bumetanide affects TRAF6
|
2
Biochanin A affects RELA
|
2
Biochanin A affects NLRP3
|
2
Bilirubin IXalpha affects EIF2AK1
|
1
1
Betulinic acid affects CHUK
|
2
Betamethasone affects ITCH
|
2
Beta-aminoarteether maleate affects STAT1
|
2
Beta-D-glucose affects CASP1
|
2
Bafilomycin A1 affects NLRP3
|
2
Bafilomycin A1 affects NFKBIA
|
2
Azelastine affects ITCH
|
2
Atorvastatin affects MYD88
|
2
Arsenite(3-) affects JUN
|
2
Arachidonic acid affects CASP1
|
1
1
Antimony(3+) affects MAPK14
|
2
|
2
|
2
Anthra[1,9-cd]pyrazol-6(2H)-one affects IKBKB
|
1
1
Anthra[1,9-cd]pyrazol-6(2H)-one affects IFNB1
|
2
Anthra[1,9-cd]pyrazol-6(2H)-one affects FOS
|
1
1
Antagonist affects IRF3
|
2
Anandamide affects NLRP3
|
2
Alvespimycin affects RELA
|
2
Aluminium(3+) affects CASP1
|
2
Allopurinol affects NLRP3
|
2
All-trans-retinoic acid affects NFKBIA
|
2
All-trans-retinoic acid affects IRF7
|
2
All-trans-retinoic acid affects FOS
|
2
Acetylsalicylic acid affects STING1
|
2
Acetylsalicylic acid affects RELA
1
|
1
Acetylcholine affects MYD88
|
2
[4-[[4-(1-benzothiophen-2-yl)-2-pyrimidinyl]amino]phenyl]-[4-(1-pyrrolidinyl)-1-piperidinyl]methanone affects IKBKB
2
|
[11C]-SORAFENIB affects MAP3K7
2
|
Trp-Leu-Leu affects FOS
|
2
Thalidomide affects NFKB1
2
|
TOZASERTIB LACTATE affects TBK1
2
|
SUNITINIB MALATE affects MAP3K7
2
|
SB-284851-BT affects MAPK14
2
|
2
|
S-adenosyl-L-methioninate affects MYD88
|
2
Ruxolitinib affects JAK1
2
|
RUBOXISTAURIN affects TBK1
2
|
PF-670462 free base affects MAPK14
2
|
Ondansetron affects ITCH
|
2
Ondansetron affects FOS
|
2
OCLACITINIB MALEATE affects TYK2
2
|
OCLACITINIB MALEATE affects JAK1
2
|
Neflamapimod affects MAPK14
2
|
Nadroparin affects FOS
2
|
2
|
|
1
1
N-tert-butyl-3-[[5-methyl-2-[4-[2-(1-pyrrolidinyl)ethoxy]anilino]-4-pyrimidinyl]amino]benzenesulfonamide affects TYK2
2
|
N-tert-butyl-3-[[5-methyl-2-[4-[2-(1-pyrrolidinyl)ethoxy]anilino]-4-pyrimidinyl]amino]benzenesulfonamide affects JAK1
2
|
N-nitrosodiethylamine affects FOS
|
2
|
2
|
1
1
N-acetyl-L-cysteine affects IKBKB
1
|
1
N-acetyl-L-cysteinate affects STAT1
|
2
N-acetyl-L-cysteinate affects NLRP3
|
2
N-acetyl-L-cysteinate affects JUN
|
2
N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide affects TBK1
2
|
|
2
|
2
MOMELOTINIB DIHYDROCHLORIDE affects JAK1
2
|
Leu-Val-Ser affects JUN
|
2
LPS with O-antigen affects NFKB1
|
2
L-prolylglycine affects IFIH1
|
2
L-kynurenine affects FOS
|
2
L-dehydroascorbic acid affects CHUK
|
2
L-cysteine affects NLRP3
|
2
L-ascorbic acid affects NLRP3
|
2
L-alanyl-L-alanine affects MAP3K7
|
2
JNJ-49095397 affects MAPK14
2
|
Interferon beta-1a affects IFNAR2
2
|
Interferon alfa-2a affects IFNAR2
2
|
Interferon alfa-2a affects IFNAR1
2
|
Hydroxychloroquine affects TLR7
2
|
Guggulsterone affects IRF3
|
2
|
2
|
2
|
1
1
Doramapimod affects MAPK14
2
|
DECERNOTINIB affects JAK1
2
|
D-threo-isocitric acid affects FOS
|
2
Beta-D-Glucose affects IFNB1
2
|
Baricitinib affects JAK1
2
|
AICA ribonucleotide affects CASP1
|
2
ABROCITINIB affects TYK2
2
|
ABROCITINIB affects JAK1
2
|
7-(3,5-dimethyl-4-isoxazolyl)-8-methoxy-1-[(1R)-1-(2-pyridinyl)ethyl]-3H-imidazo[4,5-c]quinolin-2-one affects STAT1
|
1
1
7-(3,5-dimethyl-4-isoxazolyl)-8-methoxy-1-[(1R)-1-(2-pyridinyl)ethyl]-3H-imidazo[4,5-c]quinolin-2-one affects IFNB1
|
2
6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one affects TYK2
2
|
6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one affects TBK1
2
|
6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one affects IKBKE
2
|
6-[5-[(cyclopropylamino)-oxomethyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-3-pyridinecarboxamide affects MAPK14
2
|
|
2
5-methylcytidine affects TLR7
|
1
1
|
2
5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine affects TYK2
2
|
5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine affects TBK1
2
|
5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine affects MAPK8
2
|
4-methylumbelliferone affects NFKB1
|
2
4-hydroxyphenyl retinamide affects JUN
|
2
4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-quinolinone affects TBK1
2
|
4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-quinolinone affects RIPK1
2
|
4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-quinolinone affects JAK1
2
|
4-[[5-amino-1-[(2,6-difluorophenyl)-oxomethyl]-1,2,4-triazol-3-yl]amino]benzenesulfonamide affects TYK2
2
|
4-[[5-amino-1-[(2,6-difluorophenyl)-oxomethyl]-1,2,4-triazol-3-yl]amino]benzenesulfonamide affects MAPK8
2
|
4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine affects MAPK14
2
|
4-[3-fluoro-5-(4-morpholinyl)phenyl]-N-[4-[3-(4-morpholinyl)-1,2,4-triazol-1-yl]phenyl]-2-pyrimidinamine affects MAPK8
2
|
|
2
3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine affects IKBKE
2
|
|
2
2
|
24,25-Dihydroxyvitamin D affects STAT1
|
2
2-tert-butylhydroquinone affects RELA
|
2
|
1
1
|
1
1
2-acetyl-1-pyrroline affects FOS
|
2
2-Chlorophenol affects MAPK14
2
|
|
2
|
2
17beta-estradiol affects RELA
|
2
15(S)-HETE affects NFKBIA
|
2
1-phenylpropan-2-amine affects FOS
|
2
1-fluoro-2,4-dinitrobenzene affects ITCH
|
2
1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One affects MAPK14
2
|
1,8-cineole affects RELA
|
2
1,8-cineole affects NLRP3
|
2
1,4-dithiothreitol affects MAVS
|
2
1,4-dithiothreitol affects IKBKB
1
|
1
1,4-dithiothreitol affects CASP1
|
1
1
1,1-bis(phosphonic acid) affects FOS
|
2
(S)-amphetamine affects FOS
|
2
(R)-rosmarinic acid affects JUN
|
1
1
(R)-rosmarinic acid affects FOS
|
1
1
(R)-lipoic acid affects NLRP3
|
2
(R)-lipoic acid affects NFKBIA
|
2
(R)-lipoic acid affects JUN
|
2
(R)-lipoic acid affects CASP1
|
2
(E)-cinnamaldehyde affects NLRP3
|
2
(E)-cinnamaldehyde affects IRF3
|
2
(E)-4-hydroxynon-2-enal affects TLR7
|
2
(E)-3-tosylacrylonitrile affects IRF7
|
2
(E)-3-tosylacrylonitrile affects IKBKB
|
1
1
(E)-3-tosylacrylonitrile affects CHUK
|
1
1
(20S)-ginsenoside Rg3 affects TRAF6
|
2
(-)-epigallocatechin 3-gallate affects TICAM1
|
2
(-)-epigallocatechin 3-gallate affects NLRP3
|
2
(-)-epigallocatechin 3-gallate affects NFKBIA
|
2
(-)-epigallocatechin 3-gallate affects NFKB1
|
2
(-)-epigallocatechin 3-gallate affects MAP3K7
|
2
(-)-epigallocatechin 3-gallate affects CHUK
|
2
(+)-alpha-viniferin affects STAT1
|
2
(+)-alpha-tocopherol affects NFKB1
|
2
(+)-alpha-tocopherol affects IKBKB
|
2
4'-epidoxorubicin affects RELA
|
2
3,3',5-triiodo-L-thyronine affects NLRP3
|
2
3',5'-cyclic AMP affects TRAF3
|
2
3',5'-cyclic AMP affects STAT1
|
2
3',5'-cyclic AMP affects RELA
|
2
3',5'-cyclic AMP affects IKBKB
|
1
1
Triterpenoid affects NFKBIA
|
1
1
Trichostatin A affects STAT1
1
|
1
Hyaluronic acid affects NFKB1
|
2
Cyclooctasulfur affects DDX58
|
2
Antagonist affects TLR7
|
1
1
Antagonist affects NLRP3
|
1
1
PHA-665752 affects TBK1
2
|
PHA-665752 affects IKBKE
2
|
1
1
|
3',5'-cyclic AMP affects FOS
|
2
Zoledronic acid affects NFKBIA
|
1
Zoledronic acid affects MAP3K7
|
1
Zoledronic acid affects ITCH
|
1
Zoledronic acid affects IRF3
|
1
Zinc sulfate affects RELA
1
|
Zidovudine affects NLRP3
|
1
Zidovudine affects IFNB1
|
1
Zidovudine affects FOS
|
1
Zafirlukast affects MAPK14
1
|
Wortmannin affects MAPK8
|
1
Withanolide affects MAP3K7
|
1
Withaferin A affects RELA
|
1
Wedelolactone affects RELA
1
|
Wedelolactone affects NLRP3
|
1
Vortioxetine affects FOS
|
1
Vorinostat affects NFKBIA
|
1
Vorinostat affects ITCH
|
1
Vorinostat affects IKBKG
1
|
Vitexin-7-olate affects JAK1
|
1
Vincristine affects TRAF3
|
1
Vincristine affects IRF7
|
1
Vincaleukoblastine affects STAT1
1
|
Vemurafenib affects JUN
|
1
Vasopressin affects FOS
|
1
Vanillic acid affects CASP1
|
1
Vanadium atom affects IFNB1
|
1
Valproic acid affects NFKB1
|
1
Valproic acid affects IRF7
|
1
Valeric acid affects ITCH
|
1
Valeric acid affects CASP1
|
1
Ursolic acid affects RELA
|
1
Ursolic acid affects NFKBIA
|
1
Ursolic acid affects NFKB1
|
1
Ursolic acid affects JUN
|
1
Tyrphostin AG 1478 affects RELA
|
1
Tyrphostin AG 1478 affects MAPK14
1
|
Tyrphostin AG 1478 affects JUN
|
1
Tyrphostin AG 1478 affects FOS
|
1
Tropanyl 3,5-dimethylbenzoate affects FOS
|
1
Troglitazone affects NFKB1
1
|
Troglitazone affects JUN
|
1
Troglitazone affects IFNB1
|
1
Triptorelin affects FOS
|
1
Trioxsalen affects JUN
1
|
Trimethylamine affects MAP3K7
|
1
Triethyl phosphate affects RELA
|
1
Trichostatin A affects STING1
|
1
Trichostatin A affects PYCARD
|
1
Trichostatin A affects MAP3K7
|
1
Trichostatin A affects IRF9
|
1
Trichostatin A affects IRF7
|
1
Tribromosalicylanilide affects TRAF3
|
1
Tribromosalicylanilide affects PYCARD
|
1
Tribromosalicylanilide affects NFKBIA
|
1
Tribromosalicylanilide affects MAPK14
1
|
Triacetylcellulose affects NLRP3
|
1
Trans-resveratrol affects RELA
|
1
Trans-isoeugenol affects NFKBIA
|
1
Trans-anethole affects IKBKB
1
|
Trans-aconitic acid affects NLRP3
|
1
Trans-aconitic acid affects NFKBIA
|
1
Trans-aconitic acid affects JUN
|
1
Trans-aconitic acid affects JAK1
|
1
Trans-aconitic acid affects ITCH
|
1
Trans-aconitic acid affects IKBKB
|
1
Trans-aconitic acid affects IFIH1
|
1
Trabectedin affects NFKB1
|
1
Tofacitinib affects CASP1
|
1
Titanium dioxide affects RELA
1
|
Titanium dioxide affects NLRP3
|
1
Titanium atom affects RELA
|
1
Tiotropium bromide affects RELA
|
1
Tiotropium bromide affects NFKB1
|
1
Thymine glycol affects IFIH1
|
1
Thiophenes affects IKBKB
1
|
Thioglycolate(1-) affects IFNB1
|
1
Thiocyanate affects IRF7
|
1
Thiocyanate affects IRF3
|
1
Thiamphenicol affects MAVS
|
1
Theophylline affects NFKBIA
|
1
Theophylline affects FOS
|
1
Theobromine affects NFKBIA
|
1
Theaflavin affects RELA
|
1
Thapsigargin affects MAPK14
|
1
Thallium monochloride affects MYD88
|
1
Thallium monochloride affects JUN
|
1
Tetrodotoxin affects RELA
|
1
Tetrathiomolybdate(2-) affects NLRP3
|
1
Tetraphosphorus affects RELA
|
1
Tetraphosphorus affects JUN
|
1
Tetramethylsilane affects NFKB1
|
1
Tetramethylpyrazine affects MAPK8
|
1
Tetradecanoyl group affects IFIH1
|
1
Tetracycline affects NLRP3
|
1
Tetracycline affects MAPK14
|
1
Testosterone affects JUN
|
1
Testosterone affects FOS
|
1
Testosterone affects DDX58
|
1
Teriflunomide affects PYCARD
|
1
Teriflunomide affects NLRP3
|
1
Teriflunomide affects NFKBIA
|
1
Teriflunomide affects JAK1
|
1
Teriflunomide affects CASP1
|
1
Terbutaline affects NFKB1
1
|
Telmisartan affects RELA
|
1
Telmisartan affects JUN
|
1
Tellurium atom affects CASP1
1
|
Technetium atom affects MYD88
|
1
Tebufenozide affects RELA
|
1
Tannic acid affects NFKBIA
|
1
Tannic acid affects MAPK14
|
1
Tanespimycin affects MAVS
|
1
Tanespimycin affects CHUK
|
1
Tacrolimus (anhydrous) affects ITCH
|
1
Swainsonine affects FOS
|
1
Superoxide affects NFKB1
|
1
Superoxide affects ITCH
|
1
Superoxide affects IFNB1
|
1
Sumatriptan affects FOS
|
1
Sulindac sulfide affects NFKBIA
|
1
Sulindac sulfide affects NFKB1
1
|
Sulindac sulfide affects IKBKB
1
|
Sulfur dioxide affects RELA
|
1
Sulforaphane affects STING1
|
1
Sulforaphane affects STAT1
|
1
Sulforaphane affects MAPK14
|
1
Sulforaphane affects IFNB1
|
1
Sulforaphane affects FOS
|
1
Sulforaphane affects EIF2AK1
|
1
Sulfonylureas affects NLRP3
|
1
Sulfonyldimethane affects NLRP3
|
1
Sulfometuron methyl affects RELA
|
1
Sulfapyridine affects CHUK
|
1
Succinic acid affects NLRP3
|
1
Strontium(2+) affects STING1
|
1
Streptozocin affects RELA
1
|
Streptozocin affects NLRP3
|
1
Streptozocin affects NFKB1
1
|
Streptomycin affects FOS
|
1
Sterculic acid affects NFKBIA
|
1
Staurosporine affects STAT1
|
1
Staurosporine affects NFKB1
|
1
Staurosporine affects MYD88
|
1
Staurosporine affects IRF9
|
1
Staurosporine affects IRF3
|
1
Squaric acid dibutyl ester affects ITCH
|
1
Sphingosine-1-phosphocholine affects IKBKB
|
1
Sphingosine 1-phosphate affects MAPK8
|
1
Spermidine affects STAT1
|
1
Spermidine affects RELA
|
1
Spermidine affects JUN
|
1
Soyasaponin I affects TRAF6
|
1
Sotrastaurin affects TBK1
|
1
Sodium(1+) affects TBK1
|
1
Sodium(1+) affects STAT1
|
1
Sodium(1+) affects PYCARD
|
1
Sodium(1+) affects NFKBIA
|
1
Sodium(1+) affects JAK1
|
1
Sodium(1+) affects IFNB1
|
1
Sodium hypochlorite affects NFKBIA
|
1
Sodium hydrogencarbonate affects STING1
|
1
Sodium chloride affects RELA
|
1
Sodium atom affects TRAF6
|
1
Sodium atom affects ITCH
|
1
Sodium atom affects FOS
|
1
Sodium arsenite affects NFKB1
1
|
Sodium arsenite affects JAK1
1
|
Sitosterol affects STAT2
|
1
Sitosterol affects STAT1
|
1
Sitagliptin affects NLRP3
|
1
Sitagliptin affects FOS
|
1
Sitagliptin affects CHUK
|
1
Simvastatin affects NFKBIA
|
1
Simvastatin affects NFKB1
1
|
Simvastatin affects MAP3K7
1
|
Simvastatin affects JUN
|
1
Simvastatin affects IRF3
|
1
Silver(1+) affects TANK
|
1
Silver(1+) affects RELA
|
1
Silver(1+) affects NLRP3
|
1
Silver(1+) affects NFKB1
|
1
Silver(1+) affects JUN
|
1
Silver(1+) affects IKBKE
|
1
Silver(1+) affects IFNB1
|
1
Silicon monoxide affects TANK
|
1
Silicon dioxide affects TANK
|
1
Silicon dioxide affects STING1
|
1
Silicon dioxide affects NLRP3
|
1
Silicon dioxide affects CASP1
|
1
Sepiapterin affects IKBKB
|
1
Selumetinib affects RELA
|
1
Selumetinib affects CASP1
|
1
Selenomethionine affects JUN
|
1
Selenium atom affects TICAM1
|
1
Selenium atom affects STING1
|
1
Selenium atom affects NFKB1
|
1
Selenium atom affects IRF3
|
1
Selenium atom affects IFNB1
|
1
Selenite(2-) affects NFKB1
|
1
Seaborgium atom affects STAT1
|
1
Seaborgium atom affects NFKB1
|
1
Seaborgium atom affects IRF3
|
1
Scutellarin(1-) affects PYCARD
|
1
Scutellarin(1-) affects NFKB1
|
1
Schaftoside affects MYD88
|
1
Saxagliptin affects RELA
|
1
Saquinavir affects RIPK1
|
1
Sanguinarine affects NFKB1
|
1
Salinosporamide A affects NFKBIA
|
1
Salicylic acid affects STAT1
|
1
Salicylic acid affects MYD88
|
1
Salicylic acid affects JUN
|
1
Salicylic acid affects CASP1
|
1
Salicylate affects STAT1
|
1
Salicylate affects RELA
|
1
Salicylate affects MYD88
|
1
Salicylate affects JUN
|
1
Salicylate affects CASP1
|
1
Ruxolitinib affects MAP3K7
1
|
Ruxolitinib affects IFNB1
|
1
Ruxolitinib phosphate affects MAP3K7
1
|
Rosuvastatin affects NLRP3
|
1
Rosuvastatin affects NFKBIA
|
1
Rosiglitazone affects STAT1
|
1
Rosiglitazone affects JUN
|
1
Rosiglitazone affects IKBKB
|
1
Romidepsin affects RELA
|
1
Roflumilast affects JAK1
|
1
Rocaglamide affects RELA
1
|
Ritanserin affects FOS
|
1
Rifampicin affects NLRP3
|
1
Ribosomal RNA affects TLR7
|
1
Ribonucleic acid affects JAK1
|
1
Ribonucleic acid affects ITCH
|
1
Retinoic acid affects TYK2
|
1
Retinoic acid affects MYD88
|
1
Retinoic acid affects MAVS
|
1
Retinoic acid affects JUN
|
1
Retinoic acid affects JAK1
|
1
Retinoic acid affects IRF7
|
1
Resveratrol affects PYCARD
|
1
Resveratrol affects MAPK14
|
1
Resveratrol affects IKBKB
|
1
Resveratrol affects IFNB1
|
1
Resveratrol affects FOS
1
|
Resveratrol affects CHUK
1
|
Resolvin D1 affects NFKB1
|
1
Resiquimod affects NFKBIA
|
1
Regorafenib affects JUN
|
1
Reactive oxygen species affects TLR7
|
1
Reactive oxygen species affects TICAM1
|
1
Reactive oxygen species affects STAT1
|
1
Reactive oxygen species affects PYCARD
|
1
Reactive oxygen species affects MAPK8
|
1
Reactive oxygen species affects MAP3K7
|
1
Reactive oxygen species affects ITCH
|
1
Reactive oxygen species affects IRF3
|
1
Reactive oxygen species affects IKBKB
1
|
Reactive oxygen species affects CHUK
1
|
Raloxifene affects RELA
|
1
Raloxifene hydrochloride affects STAT1
|
1
Raloxifene hydrochloride affects RELA
1
|
Quinpirole affects FOS
|
1
Quinoxaline affects IKBKB
|
1
Quinolinic acid affects FOS
|
1
Quinazolines affects MAPK14
1
|
Quinalizarin affects RELA
|
1
Quinacrine affects JUN
|
1
Quinacrine affects FOS
|
1
|
1
Pyruvic acid affects CASP1
|
1
Pyrrolidine affects TICAM1
|
1
Pyrrolidine affects NFKBIA
|
1
Pyrrolidine affects MYD88
|
1
Pyrrole-2-carboxylic acid affects STAT1
|
1
Pyrrole-2-carboxylic acid affects IFNB1
|
1
Pyrimidines affects MAPK14
1
|
Pyrimidine affects STAT1
|
1
Pyridoxine affects NFKB1
|
1
Pyridazine affects IKBKB
|
1
Pyraclofos affects NFKBIA
|
1
Purpurogallin affects FOS
|
1
Puromycin(1+) affects FOS
|
1
Purine-6-thiol affects RELA
|
1
Punicalagin affects CASP1
|
1
Pseudouridine affects IFNB1
|
1
Pseudouridine affects IFIH1
|
1
Protein kinase inhibitor affects RELA
1
|
Protein kinase inhibitor affects NFKB1
1
|
Protein kinase inhibitor affects MAPK14
1
|
Protein kinase inhibitor affects IKBKB
1
|
Prostaglandin J2 affects IKBKB
|
1
Prostaglandin J2 affects FOS
|
1
Prostaglandin I2 affects MAPK14
|
1
Prostaglandin E2-UM affects STAT2
|
1
Prostaglandin E2-UM affects NFKB1
|
1
Prostaglandin E2-UM affects IFNB1
|
1
Prostaglandin E2 affects RELA
|
1
Prostaglandin E2 affects IFNB1
|
1
Prostaglandin A1 affects NFKB1
|
1
Propranolol affects CHUK
|
1
Propranolol affects CASP1
|
1
Propionic acid affects CASP1
|
1
Propan-2-ol affects JUN
1
|
Propan-2-ol affects FOS
1
|
Progesterone affects TICAM1
|
1
Progesterone affects NLRP3
|
1
Progesterone affects NFKB1
|
1
Progesterone affects MAPK8
1
|
Progesterone affects MAPK14
|
1
Progesterone affects JUN
|
1
Progesterone affects IFNB1
|
1
Progesterone affects FOS
|
1
Probenecid affects FOS
|
1
Pregabalin affects FOS
|
1
Pravastatin affects JUN
|
1
Potassium(1+) affects TBK1
|
1
Potassium(1+) affects ITCH
|
1
Potassium iodide affects NFKBIA
|
1
Potassium dihydrogen phosphate affects MAPK8
|
1
Potassium chloride affects PYCARD
|
1
Polyphenol affects TICAM1
|
1
Polyphenol affects MYD88
|
1
Polyphenol affects IKBKB
|
1
Polyinosinic:polycytidylic acid affects IFNB1
|
1
Polyinosinic-polycytidylic acid affects TRAF6
|
1
Polyinosinic-polycytidylic acid affects IFIH1
|
1
Polyinosinic acid affects RELA
|
1
Poly(vinyl alcohol) polymer affects CASP1
|
1
|
1
Poly(cytidylic acid) affects RELA
|
1
Poly(cytidylic acid) affects IFNB1
|
1
Platycodin D affects RELA
1
|
Pirfenidone affects NLRP3
|
1
Pirfenidone affects JUN
|
1
Pioglitazone affects NLRP3
|
1
Pioglitazone affects NFKB1
|
1
Pioglitazone affects MYD88
|
1
Pioglitazone affects JUN
|
1
Pioglitazone affects IKBKB
|
1
Pioglitazone affects IFNB1
|
1
Pioglitazone affects CHUK
|
1
Piceatannol affects TBK1
1
|
Piceatannol affects RELA
|
1
Piceatannol affects NFKBIA
|
1
Piceatannol affects MAP3K7
|
1
Piceatannol affects JUN
|
1
Piceatannol affects IKBKE
1
|
Piceatannol affects CASP1
|
1
Phosphorothioate oligonucleotide affects TLR7
1
|
Phosphoenolpyruvic acid affects PYCARD
|
1
Phosphatidylinositol phosphate affects MAPK8
|
1
Phosphatidyl-L-serine affects NLRP3
|
1
Phosphatidic acid affects RELA
|
1
Phosphatidic acid affects NFKB1
|
1
Phosphate(3-) affects RIPK1
|
1
Phorbol 12,13-dibutanoate affects NFKBIA
|
1
Phenylephrine affects NFKBIA
|
1
Phenyl-N-tert-butylnitrone affects RELA
1
|
Phenyl-N-tert-butylnitrone affects NFKB1
1
|
Phenyl isocyanate affects NFKBIA
|
1
Phenobarbital affects MAPK8
|
1
Phenethyl isothiocyanate affects STAT1
|
1
Phenethyl isothiocyanate affects NFKBIA
|
1
Phenethyl isothiocyanate affects IRF3
|
1
Phenethyl caffeate affects MAPK8
|
1
Phenethyl caffeate affects JUN
|
1
Phenethyl caffeate affects IKBKB
|
1
Phenazine-1-carboxylate affects TYK2
|
1
Phenazine-1-carboxylate affects NLRP3
|
1
Pevonedistat affects NFKB1
|
1
Pevonedistat affects ITCH
|
1
Pevonedistat affects CHUK
|
1
Permethrin affects FOS
|
1
Pentobarbital affects FOS
|
1
Parthenolide affects TICAM1
|
1
Parthenolide affects MAPK8
|
1
Parthenolide affects JAK1
|
1
Paricalcitol affects STAT1
|
1
Paricalcitol affects RELA
|
1
Paracetamol affects RELA
1
|
Paracetamol affects NFKB1
|
1
Palmitoleic acid affects RELA
|
1
Paeoniflorin affects RELA
|
1
Paeoniflorin affects NLRP3
|
1
Paeoniflorin affects CASP1
|
1
Paclitaxel affects NFKB1
|
1
Paclitaxel affects FOS
|
1
Oxidopamine affects JUN
|
1
Oxaloacetic acid affects RELA
|
1
Oxaliplatin affects STAT1
|
1
Oxaliplatin affects NFKB1
|
1
Oxaliplatin affects CHUK
|
1
Oxalic acid affects NLRP3
|
1
Oxalic acid affects NFKBIA
|
1
Oxalic acid affects JUN
|
1
Oseltamivir affects TLR7
|
1
Oroxylin A(1-) affects STAT1
|
1
Organometallic compound affects CASP1
1
|
Omega interferon affects IFNAR2
1
|
Omega interferon affects IFNAR1
1
|
Olmesartan affects MAPK14
|
1
Oleoyl ethanolamide affects RELA
|
1
Oleic acid affects NLRP3
|
1
Oleic acid affects NFKBIA
|
1
Oleic acid affects JUN
|
1
Oleic acid affects ITCH
|
1
Oleanolic acid affects RELA
|
1
Okadaic acid affects RELA
|
1
Okadaic acid affects NLRP3
|
1
Okadaic acid affects MAPK8
|
1
Okadaic acid affects JUN
|
1
Okadaic acid affects FOS
|
1
Octanoic acid affects MAPK14
1
|
Nucleoside triphosphate affects IFIH1
|
1
Novobiocin(1-) affects EIF2AK1
|
1
Nordihydroguaiaretic acid affects NFKB1
|
1
Nordihydroguaiaretic acid affects FOS
1
|
Noradrenaline affects RELA
|
1
Noradrenaline affects NFKB1
|
1
Nogalamycin affects IFIH1
|
1
Nocodazole affects NLRP3
|
1
Nitrosobenzene affects IRF7
|
1
Nitroso group affects JAK1
|
1
Nitroflurbiprofen affects RELA
1
|
Nitrocellulose affects MYD88
|
1
Nitric oxide affects TYK2
|
1
Nitric oxide affects TRAF6
|
1
Nitric oxide affects TBK1
|
1
Nitric oxide affects PYCARD
|
1
Nitric oxide affects ITCH
|
1
Nitric oxide affects IRF3
|
1
Nitric oxide affects IFNB1
|
1
Nintedanib affects TYK2
1
|
Nintedanib affects TBK1
1
|
Nintedanib affects RIPK1
1
|
Nintedanib affects MAPK8
1
|
Nintedanib affects MAP3K7
1
|
Nintedanib affects JAK1
1
|
Nintedanib affects IKBKE
1
|
Nintedanib esylate affects TYK2
1
|
Nintedanib esylate affects TBK1
1
|
Nintedanib esylate affects RIPK1
1
|
Nintedanib esylate affects MAPK8
1
|
Nintedanib esylate affects MAP3K7
1
|
Nintedanib esylate affects JAK1
1
|
Nintedanib esylate affects IKBKE
1
|
Nimesulide affects IFNB1
1
|
Nifedipine affects TRIM25
|
1
Nickel(2+) affects IKBKE
|
1
Mycophenolate mofetil affects RELA
|
1
Mycophenolate mofetil affects NFKB1
|
1
Morphine(1+) affects PYCARD
|
1
Morphine(1+) affects NLRP3
|
1
Morphine(1+) affects MAVS
|
1
Morphine(1+) affects MAP3K7
|
1
Morphine(1+) affects IRF7
|
1
Montelukast affects MAPK14
1
|
Montelukast sodium affects MAPK14
1
|
Monocrotaline affects NLRP3
|
1
Monensin A affects TANK
|
1
Monensin A affects NFKBIA
|
1
Monensin A affects NFKB1
|
1
Monensin A affects IFNB1
|
1
Momelotinib affects TBK1
|
1
Momelotinib affects CHUK
1
|
Mitoxantrone affects NFKBIA
|
1
Mitomycin C affects NLRP3
|
1
Mithramycin affects RELA
|
1
Mithramycin affects JUN
|
1
Minocycline affects MAPK8
|
1
Minocycline affects CHUK
|
1
Mifepristone affects STAT1
|
1
Mevalonic acid affects IRF3
|
1
Mevalonic acid affects CASP1
|
1
Metyrapone affects NFKB1
|
1
Methylphosphonate(2-) affects RELA
|
1
Methyllycaconitine affects MAPK8
|
1
Methyl methanesulfonate affects NFKB1
|
1
Methyl methacrylate affects JAK1
|
1
Methyl isocyanate affects MAPK8
|
1
Methoxyfenozide affects RELA
|
1
Methotrexate affects ITCH
|
1
Methamphetamine affects FOS
|
1
Messenger RNA affects MAPK14
|
1
Messenger RNA affects IFIH1
|
1
Messenger RNA affects DDX58
|
1
Messenger RNA affects CASP1
|
1
Meso-dihydroguaiaretic acid affects JUN
1
|
Meso-dihydroguaiaretic acid affects FOS
1
|
Mesalamine affects STAT1
|
1
Mesalamine affects NFKBIA
|
1
Mesalamine affects NFKB1
|
1
Mercury(2+) affects NLRP3
|
1
Mercury(0) affects EIF2AK1
1
|
Mercury dichloride affects NFKBIA
1
|
Mercaptopurine affects JUN
|
1
Mercaptoethanol affects MAPK8
1
|
Menatetrenone affects CASP1
|
1
Mastoparan-A affects RELA
|
1
Masoprocol affects FOS
1
|
Maslinic acid affects NFKBIA
|
1
Mannooligosaccharide affects RELA
|
1
Manganese(II) chloride affects NFKBIA
1
|
Manganese(2+) affects RELA
|
1
Manganese(2+) affects NFKBIA
|
1
Malonaldehyde affects RELA
|
1
Maleic acid affects FOS
|
1
Magnesium(2+) affects NFKBIA
|
1
Magnesium(2+) affects JUN
|
1
Magnesium oxide affects RELA
|
1
Magnesium atom affects NFKBIA
|
1
Magnesium atom affects NFKB1
|
1
Magnesium atom affects IKBKB
|
1
MTOR inhibitor affects RIPK1
|
1
Lovastatin affects JUN
|
1
Lovastatin affects JAK1
1
|
Lithium(1+) affects IFNAR1
|
1
Lithium chloride affects NFKBIA
|
1
Lithium chloride affects JUN
|
1
Lithium chloride affects FOS
|
1
Lisinopril affects MAP3K7
|
1
Liraglutide affects PYCARD
|
1
Liraglutide affects CASP1
|
1
Lipoxin A4 affects MAPK14
|
1
Lipoxin A4 affects JUN
|
1
Lipopolysaccharide affects TBK1
|
1
Lipopolysaccharide affects TANK
|
1
Lipopolysaccharide affects STAT2
|
1
Lipopolysaccharide affects RIPK1
|
1
Lipopolysaccharide affects JAK1
|
1
Lipopolysaccharide affects IRF7
|
1
Lipopolysaccharide affects IKBKG
|
1
Lipopolysaccharide affects IFNAR1
|
1
Lipid A(4-) (E. coli) affects NFKBIA
|
1
Lipid A(4-) (E. coli) affects MYD88
|
1
Lipid A(4-) (E. coli) affects IFNB1
|
1
Linoleic acid affects NLRP3
|
1
Lincomycin affects TRIM25
|
1
Linagliptin affects RELA
|
1
Levomethorphan affects RELA
|
1
Levomethorphan affects NFKBIA
|
1
Leptomycin B affects NFKBIA
|
1
Leptomycin B affects MAP3K7
|
1
Leptomycin B affects JUN
|
1
Leptomycin B affects IFNB1
|
1
Leptomycin B affects FOS
|
1
Lenalidomide affects IRF7
|
1
Leflunomide affects JAK1
|
1
Leflunomide affects CASP1
|
1
Lawrencium atom affects RELA
|
1
Latanoprost affects NFKBIA
|
1
Lanosterol affects IFNB1
|
1
Lactacystin affects TRAF3
|
1
Kynurenine affects MYD88
|
1
Kynurenic acid affects NLRP3
|
1
Ketone body affects NLRP3
|
1
Ketanserin affects FOS
|
1
Kamebakaurin affects NFKB1
1
|
Kainic acid affects FOS
|
1
Kaempferol oxoanion affects RIPK1
|
1
Kaempferol oxoanion affects RELA
|
1
Kaempferol oxoanion affects NLRP3
|
1
Kaempferol oxoanion affects JUN
|
1
Kaempferol oxoanion affects FOS
|
1
Ivermectin affects IRF3
|
1
Itaconate(2-) affects IFNB1
|
1
Isotretinoin affects STAT1
|
1
Isotretinoin affects MAVS
|
1
Isotretinoin affects IRF7
|
1
Isorhamnetin affects CASP1
|
1
Isoquinoline affects IKBKB
|
1
Isoprenaline affects NFKBIA
|
1
Isoprenaline affects JUN
|
1
Isoprenaline affects IFNB1
|
1
Isoliquiritigenin(1-) affects PYCARD
|
1
Isoliquiritigenin(1-) affects IRF3
|
1
Isoliquiritigenin affects TBK1
|
1
Isoliquiritigenin affects RELA
1
|
Isoflurane affects NFKBIA
|
1
Isoflurane affects FOS
|
1
Isoflavones affects RELA
1
|
Isocyanic acid affects RELA
|
1
Isocyanic acid affects NFKBIA
|
1
Isocitrate(3-) affects NLRP3
|
1
Irinotecan affects NLRP3
|
1
Irbesartan affects JUN
|
1
Irbesartan affects FOS
|
1
Iodoquinol affects MAPK14
1
|
Indometacin affects RELA
1
|
Indometacin affects NFKB1
1
|
Indole-3-methanol affects NFKBIA
|
1
Imperatorin affects JAK1
|
1
Imperatorin affects CASP1
|
1
Imidazol-4-ylacetic acid affects MAVS
|
1
Imatinib methanesulfonate affects RELA
1
|
Imatinib methanesulfonate affects NFKB1
1
|
Ifosfamide affects IFNB1
1
|
Hypothemycin affects MAP3K7
1
|
Hypochlorous acid affects ITCH
|
1
Hyperforin affects STAT1
|
1
Hydroxychloroquine affects NFKB1
|
1
Hydroxychloroquine affects IKBKG
|
1
Hydroquinone affects RELA
1
|
Hydroquinone affects NFKB1
1
|
Hydrogen sulfide affects RELA
|
1
Hydrogen sulfide affects NFKB1
|
1
Hydrogen sulfide affects IKBKB
|
1
Hydrogen peroxide affects TRAF6
|
1
Hydrogen peroxide affects JUN
|
1
Hydrogen peroxide affects ITCH
|
1
Hydrogen fluoride affects TBK1
|
1
Hydrogen chloride affects RELA
|
1
Hydrogen chloride affects ITCH
|
1
Hydrogen chloride affects IFNB1
|
1
Hyaluronic acid affects NFKBIA
|
1
Hyaluronic acid affects MYD88
|
1
Hyaluronic acid affects JUN
|
1
Hyaluronan affects MYD88
|
1
Hexadecanoic acid affects STING1
|
1
Hexadecanoic acid affects MAPK8
|
1
Hexadecane affects MYD88
|
1
Hexadecane affects MAPK8
|
1
Hexadecane affects IKBKB
|
1
Hexadecane affects IFNAR1
|
1
Hexadecan-1-ol affects JUN
|
1
Hexachlorophene affects MAPK14
1
|
Heterocyclic compound affects RELA
1
|
Hesperidin affects NFKB1
|
1
Hesperidin affects MAPK8
|
1
Hesperadin affects TYK2
1
|
Haloperidol affects RIPK1
|
1
Haloperidol affects RELA
|
1
Haloperidol affects NFKB1
|
1
Guggulsterone affects TICAM1
|
1
Guggulsterone affects RELA
|
1
Goniothalamin affects MAP3K7
1
|
Glycyrrhizinic acid affects NFKBIA
|
1
Glycyrrhizinic acid affects MYD88
|
1
Glycyrrhizinate(3-) affects NFKB1
|
1
Glycyrrhizinate(3-) affects IRF3
|
1
Glycyrrhizinate(3-) affects IFNB1
|
1
Glycine betaine affects RELA
1
|
Glutathione affects MAPK14
|
1
Glutathione affects MAP3K7
|
1
Glutathione affects IKBKB
1
|
Glutathione affects CHUK
1
|
Glutathione disulfide affects RELA
1
|
Glutathione disulfide affects NFKB1
1
|
Glutamate(2-) affects IKBKG
|
1
Glucosamine affects NFKBIA
|
1
Glucosamine affects NFKB1
|
1
Glucosamine affects JUN
|
1
Glucocorticoid affects NFKBIA
|
1
Glucocorticoid affects MAP3K7
|
1
Glucocorticoid affects IFNB1
|
1
Glucocorticoid affects FOS
|
1
Ginsenoside Rg1 affects CASP1
|
1
Ginsenoside Rb3 affects JUN
|
1
Ginsenoside Rb3 affects FOS
|
1
Gentamycin affects RELA
1
|
Gemcitabine affects RELA
|
1
Geldanamycin affects TBK1
|
1
Geldanamycin affects RIPK1
|
1
Geldanamycin affects NLRP3
|
1
Geldanamycin affects MAVS
|
1
Geldanamycin affects MAP3K7
|
1
Geldanamycin affects EIF2AK1
|
1
Geldanamycin affects DDX58
|
1
Geldanamycin affects CHUK
|
1
Gastrin-17 affects RELA
1
|
Gastrin-17 affects NFKB1
1
|
Ganglioside affects IFNB1
|
1
Gamma-tocotrienol affects NLRP3
|
1
Gamma-tocotrienol affects JAK1
|
1
Gamma-tocotrienol affects CHUK
|
1
Gamma-aminobutyric acid affects NLRP3
|
1
Gamma-aminobutyric acid affects FOS
|
1
Gallic acid affects TICAM1
|
1
Gallic acid affects STING1
|
1
Gallic acid affects NLRP3
|
1
Gallic acid affects NFKBIA
|
1
Gallic acid affects NFKB1
|
1
Gallic acid affects MAPK8
|
1
Gallic acid affects MAP3K7
|
1
Gallic acid affects FOS
|
1
Furosemide affects MAP3K7
|
1
Fumonisin B1 affects RELA
|
1
Fumigaclavine C(1+) affects CASP1
|
1
Fumaric acid affects NLRP3
|
1
Fucoxanthin affects JUN
|
1
Fucoxanthin affects CASP1
|
1
Formic acid affects TLR7
|
1
Formic acid affects NFKBIA
|
1
Fluvastatin affects RELA
|
1
Fluticasone propionate affects IKBKB
|
1
Fluticasone propionate affects CHUK
|
1
Fluoxetine hydrochloride affects STAT1
|
1
Fluorescein affects RIPK1
|
1
Flufenamic acid affects CASP1
|
1
Fludarabine affects STAT1
1
|
Filipin III affects STAT1
|
1
Filipin III affects NFKBIA
|
1
Filgotinib affects JAK1
|
1
Fidaxomicin affects STAT2
|
1
Ferulic acid affects NLRP3
|
1
Ferulic acid affects MAPK8
1
|
Famotidine affects NFKB1
|
1
Everolimus affects RELA
|
1
Etoricoxib affects MAPK14
1
|
Ethylenediaminetetraacetic acid affects NLRP3
|
1
Ethylenediaminetetraacetic acid affects CASP1
|
1
|
1
|
1
Ethidium bromide affects IFIH1
|
1
Ethanolamine affects IKBKB
|
1
Etanercept affects OAS3
|
1
Etanercept affects OAS2
|
1
Erythromycin A affects NLRP3
|
1
Erythromycin A affects JUN
|
1
Erlotinib hydrochloride affects TBK1
|
1
Erlotinib hydrochloride affects RIPK1
|
1
Erlotinib hydrochloride affects IRF3
|
1
Eriodictyol affects TBK1
1
|
Ergosterol affects RELA
|
1
Ergosterol affects IKBKB
|
1
Ergosterol affects DDX58
|
1
Eplerenone affects NLRP3
|
1
Epalrestat affects NLRP3
|
1
Enzyme inhibitor affects TRIM25
1
|
Enzyme inhibitor affects RELA
1
|
Enzyme inhibitor affects MAVS
1
|
Enzyme inhibitor affects JUN
1
|
Enzyme inhibitor affects IRF9
1
|
Enzyme inhibitor affects IKBKG
1
|
Enzyme inhibitor affects IKBKB
1
|
Emodin(1-) affects TRAF6
|
1
Emodin(1-) affects RELA
|
1
Emodin(1-) affects NLRP3
|
1
Emodin(1-) affects NFKBIA
|
1
Emodin(1-) affects IFNAR1
|
1
Emedastine affects ITCH
|
1
Ellagic acid affects NFKB1
|
1
Electrophilic reagent affects IKBKB
|
1
Ecgonine benzoate affects MYD88
|
1
Doxycycline affects RELA
|
1
Doxycycline affects NFKBIA
|
1
Doxycycline affects IKBKB
|
1
Doxycycline affects IFNB1
|
1
Doxycycline affects FOS
|
1
Doxorubicin affects RIPK1
|
1
Doxorubicin affects NLRP3
|
1
Doxorubicin affects MAPK14
1
|
Dorsomorphin affects PYCARD
|
1
Divinyl sulfone affects NLRP3
|
1
Divanadium pentaoxide affects STAT1
|
1
Diterpenoid affects JUN
|
1
Disulfiram affects RELA
1
|
Disulfiram affects CASP1
|
1
Disodium selenite affects RELA
1
|
Disodium cromoglycate affects ITCH
|
1
Dipyrithione affects STAT1
|
1
Diphenhydramine affects ITCH
|
1
Diphenhydramine affects FOS
|
1
Dinitrogen affects RELA
|
1
Dinitrogen oxide affects FOS
|
1
Diminazene affects RELA
1
|
Dimethyl sulfoxide affects STAT1
|
1
Dimethyl sulfoxide affects PYCARD
|
1
Dimethyl sulfoxide affects MAPK8
|
1
Dimethyl sulfoxide affects MAP3K7
|
1
Dimethyl sulfoxide affects IFNB1
|
1
Dimethyl sulfoxide affects FOS
|
1
Dimethyl sulfoxide affects CHUK
|
1
Dimethyl sulfoxide affects CASP1
|
1
Dimethyl sulfide affects CASP1
|
1
Dimethyl fumarate affects RELA
1
|
Dihydrogen affects TANK
|
1
Dihydrogen affects CASP1
|
1
Dihydroartemisinin affects TICAM1
|
1
Dihydroartemisinin affects RIPK1
|
1
Dihydroartemisinin affects MAP3K7
|
1
Dihydroartemisinin affects IKBKB
|
1
Digitoxigenin affects STAT1
|
1
Diclofenac affects ITCH
|
1
Dibenziodolium affects RELA
|
1
Dibenziodolium affects NLRP3
|
1
Dibenziodolium affects NFKB1
1
|
Dibenziodolium affects JAK1
|
1
Dibenziodolium affects CASP1
|
1
Dibenziodolium chloride affects NLRP3
|
1
Dibenziodolium chloride affects CASP1
|
1
Diarsenic trioxide affects STAT1
1
|
Diarsenic trioxide affects NLRP3
|
1
Diarsenic trioxide affects NFKB1
1
|
Diarsenic trioxide affects MAPK8
1
|
Diarsenic trioxide affects FOS
1
|
Diarsenic trioxide affects CASP1
|
1
Diallyl trisulfide affects TRAF6
|
1
DiOC18(3) dye affects RELA
|
1
Dexmedetomidine affects STAT1
|
1
Dexamethasone affects TICAM1
|
1
Dexamethasone affects TBK1
|
1
Dexamethasone affects STAT1
|
1
Dexamethasone affects ITCH
|
1
Dexamethasone affects IRF7
|
1
Dexamethasone affects CASP1
|
1
Desmosterol affects RELA
|
1
Desloratadine affects ITCH
|
1
Desferrioxamine B affects RIPK1
|
1
Desferrioxamine B affects RELA
|
1
Deoxynivalenol affects NFKB1
1
|
Deoxynivalenol affects MAPK8
1
|
Deoxycholate affects RIPK1
|
1
Delta-tocotrienol affects RELA
|
1
Delta-tocotrienol affects JUN
|
1
Delphinidin chloride affects FOS
|
1
Dehydroascorbic acid affects NFKBIA
|
1
Daunorubicin(1+) affects NFKBIA
|
1
Dasatinib (anhydrous) affects NLRP3
|
1
Dactolisib affects STAT1
|
1
Cytochalasin D affects STAT1
1
|
Cytochalasin D affects IFNB1
|
1
Cytochalasin B affects MAPK8
|
1
Cytochalasin B affects MAPK14
|
1
Cytarabine affects RELA
1
|
Cysteamine affects JUN
|
1
Cypermethrin affects MAPK8
1
|
Cyclosporin A affects TRIM25
|
1
Cyclosporin A affects STAT2
|
1
Cyclosporin A affects NFKBIA
|
1
Cyclosporin A affects MAPK14
|
1
Cyclosporin A affects JUN
|
1
Cyclosporin A affects IFNB1
|
1
Cyclosporin A affects CASP1
|
1
Cyclopentasulfur affects NLRP3
|
1
Cyclopentasulfur affects JUN
|
1
Cyclooctasulfur affects IRF3
|
1
Cycloheximide affects RIPK1
|
1
Cycloheximide affects RELA
|
1
Cycloheximide affects NFKB1
|
1
Cycloheximide affects MAPK8
|
1
Cycloheximide affects JUN
|
1
Cycloheximide affects ITCH
|
1
Cycloheximide affects IRF3
|
1
Cycloheximide affects IFNB1
|
1
Cycloheximide affects FOS
|
1
Cyanidin 3-O-beta-D-glucoside affects RELA
1
|
Cudratricusxanthone A affects RELA
|
1
Crotonaldehyde affects PYCARD
|
1
Crotonaldehyde affects CASP1
|
1
Crocidolite asbestos affects MAPK14
1
|
Coumermycin A1 affects EIF2AK1
|
1
Costunolide affects RELA
|
1
Costunolide affects NFKB1
|
1
Costunolide affects MAP3K7
|
1
Costunolide affects FOS
|
1
Corticosterone affects RNF135
|
1
Corticosterone affects NFKB1
|
1
Copper(II) sulfide affects TANK
|
1
Copper(2+) affects NLRP3
|
1
Copper(2+) affects IFNB1
|
1
Copper atom affects IKBKB
1
|
Copper atom affects EIF2AK1
1
|
Colchicine affects STAT1
1
|
Colchicine affects PYCARD
|
1
Coenzyme Q10 affects RELA
|
1
Coenzyme Q10 affects NFKBIA
|
1
Coenzyme A affects CASP1
|
1
Cobimetinib affects STAT1
|
1
Cobalt dichloride affects CASP1
|
1
Clondronate(2-) affects NLRP3
|
1
Clofibric acid affects EIF2AK1
|
1
Clemastine affects NLRP3
|
1
Clarithromycin affects RELA
|
1
Cinacalcet affects NLRP3
|
1
Cimetidine affects ITCH
|
1
Cilostazol affects NLRP3
|
1
Cilostazol affects MAPK14
|
1
Cilostazol affects JUN
|
1
Cilostazol affects FOS
|
1
Ciguatoxin CTX1B affects NLRP3
|
1
Ciguatoxin CTX1B affects NFKBIA
|
1
Ciglitazone affects RELA
1
|
Ciglitazone affects NFKB1
1
|
Chromium atom affects NLRP3
|
1
Chondroitin sulfate affects IFIH1
|
1
Cholesterol affects STAT1
|
1
Cholesterol affects NFKB1
|
1
Cholesterol affects ITCH
|
1
Cholesterol affects IFNAR1
|
1
Cholesterol affects CASP1
|
1
Cholest-5-en-3-ol affects NFKB1
|
1
Cholest-5-en-3-ol affects CASP1
|
1
Chlorpyrifos affects STAT1
|
1
Chlorpromazine affects RIPK1
|
1
Chloroxine affects NFKB1
|
1
Chloroquine affects TICAM1
|
1
Chloroform affects TRAF3
|
1
Chloroform affects RIPK1
|
1
Chloroethene affects PYCARD
|
1
Chloramphenicol affects TRIM25
|
1
Chloramphenicol affects RELA
|
1
Chloramphenicol affects NFKBIA
|
1
Chloramphenicol affects MAVS
|
1
Chloramphenicol affects IFNB1
|
1
Chenodeoxycholic acid affects JUN
|
1
Chenodeoxycholic acid affects CASP1
|
1
Chelerythrine affects MAPK8
|
1
Chelerythrine affects JUN
|
1
Cetrorelix affects RELA
1
|
Ceruletide affects TRAF6
|
1
Ceruletide affects STAT2
|
1
Ceruletide affects NFKB1
|
1
Cefmetazole sodium affects TANK
|
1
Carvedilol affects RELA
|
1
Carvedilol affects JUN
|
1
Cardenolide affects JAK1
|
1
Carbon monoxide affects TICAM1
|
1
Carbon monoxide affects STAT1
|
1
Carbon monoxide affects PYCARD
|
1
Carbon monoxide affects NFKB1
|
1
Carbon monoxide affects MYD88
|
1
Carbon monoxide affects IFNB1
|
1
Carbon monoxide affects FOS
|
1
Cantharidin affects MAPK8
|
1
Calyculin A affects RELA
1
|
Calcium(2+) affects TRIM25
|
1
Calcium(2+) affects TLR7
|
1
Calcium(2+) affects TBK1
|
1
Calcium(2+) affects STING1
|
1
Calcium(2+) affects MAPK8
|
1
Calcium(2+) affects MAP3K7
|
1
Calcium(2+) affects JUN
|
1
Calcium(2+) affects ITCH
|
1
Calcium(2+) affects IKBKB
|
1
Calcium dichloride affects FOS
|
1
Calcium atom affects IRF3
|
1
Calcium atom affects CASP1
|
1
Calcitriol affects MAPK8
1
|
Calcitriol affects JUN
|
1
Cadmium(2+) affects PYCARD
|
1
Cadmium(2+) affects JAK1
|
1
Cadmium(2+) affects EIF2AK1
|
1
Cadmium dichloride affects NFKB1
|
1
Cadmium dichloride affects JAK1
|
1
Cadmium dichloride affects CHUK
1
|
Cadmium atom affects RELA
1
|
Cadmium atom affects NLRP3
|
1
Cadmium atom affects IKBKB
|
1
Cadmium atom affects IFIH1
|
1
Cadmium atom affects EIF2AK1
1
|
Cadmium atom affects CHUK
1
|
Butyric acid affects FOS
|
1
Bumetanide affects FOS
|
1
Bufadienolide affects JAK1
|
1
Budesonide affects RELA
|
1
Budesonide affects IFNB1
|
1
Bucladesine affects RELA
|
1
Bryostatin 1 affects NLRP3
|
1
Brefeldin A affects NFKBIA
|
1
Brefeldin A affects JUN
|
1
Bradykinin affects IRF7
|
1
Bradykinin affects IFNB1
|
1
Bisphenol A affects PYCARD
|
1
Bis(maltolato)oxovanadium(IV) affects JUN
1
|
Bis(maltolato)oxovanadium(IV) affects FOS
1
|
Bis(2-ethylhexyl) phthalate affects MAPK8
|
1
Biphenylene affects IFNB1
|
1
Biochanin A affects JUN
|
1
Bimatoprost affects NFKBIA
|
1
Bilobalide affects RELA
|
1
Bilobalide affects NFKBIA
|
1
Bilobalide affects MAP3K7
|
1
Bilobalide affects IKBKB
|
1
Bilirubin IXalpha affects NLRP3
|
1
Bilirubin IXalpha affects CASP1
|
1
Betulinic acid affects NFKBIA
|
1
Beta-maltose affects PYCARD
|
1
Beta-eudesmol affects CASP1
|
1
Beta-carotene affects NLRP3
|
1
Beta-carotene affects JUN
|
1
Beta-carotene affects FOS
|
1
Beta-D-glucose affects STAT1
|
1
Beta-D-glucose affects RELA
|
1
Beta-D-glucose affects PYCARD
|
1
Beta-D-fructofuranose affects NLRP3
|
1
Benzyl isothiocyanate affects NLRP3
|
1
Benzoic acid affects IKBKB
|
1
Benzo[a]pyrene affects IFNB1
|
1
Benfotiamine affects RELA
|
1
Barium(2+) affects NLRP3
|
1
Barium(2+) affects JUN
|
1
Barium(2+) affects ITCH
|
1
Barium(2+) affects FOS
|
1
Barium atom affects TLR7
|
1
Bafilomycin A1 affects IFNB1
|
1
Azithromycin affects STAT1
|
1
Azithromycin affects RELA
|
1
Azithromycin affects JUN
|
1
Azadirachtin A affects TRAF6
|
1
Atorvastatin affects TICAM1
|
1
Atorvastatin affects NFKBIA
|
1
Atorvastatin affects NFKB1
|
1
Atorvastatin affects IFNB1
|
1
Atorvastatin affects FOS
|
1
Astaxanthin affects JAK1
|
1
Astaxanthin affects IKBKB
|
1
Astaxanthin affects CASP1
|
1
Astatine atom affects RELA
|
1
Astatine atom affects JUN
|
1
Asiatic acid affects NLRP3
|
1
Ascorbic acid affects NLRP3
|
1
Artesunate affects TRAF6
|
1
Arsenic(3+) affects PYCARD
|
1
Arsenic atom affects RELA
|
1
Arsenic atom affects MAPK8
1
|
Arsenic atom affects IFNB1
|
1
Arachidonic acid affects NFKBIA
|
1
Arachidonic acid affects MAPK14
|
1
Arachidonic acid affects JUN
|
1
Arachidonic acid affects FOS
|
1
Aprepitant affects ITCH
|
1
Antioxidant affects NLRP3
|
1
Antioxidant affects NFKB1
|
1
Antimony(3+) affects MAPK8
|
1
Anthraquinone affects NLRP3
|
1
Anthra[2,3-b]benzo[d]thiophene affects CASP1
|
1
Anthra[1,9-cd]pyrazol-6(2H)-one affects STAT1
|
1
Anthra[1,9-cd]pyrazol-6(2H)-one affects RIPK1
|
1
|
1
|
1
Anthra[1,9-cd]pyrazol-6(2H)-one affects IRF7
|
1
Anthra[1,9-cd]pyrazol-6(2H)-one affects CASP1
|
1
Antagonist affects TRIM25
|
1
Antagonist affects NFKBIA
|
1
Antagonist affects JAK1
|
1
Antagonist affects CASP1
|
1
Angiotensin affects NLRP3
|
1
Andrographolide affects JUN
1
|
Andrographolide affects FOS
1
|
Anacardic acid affects MAP3K7
1
|
Ammonium chloride affects NFKB1
|
1
Amlodipine affects MAPK14
|
1
Amitriptyline affects NLRP3
|
1
Aminoguanidine affects TANK
|
1
Amino acid affects STAT1
|
1
Amino acid affects IFNB1
|
1
Amino acid affects IFIH1
|
1
Amino acid affects FOS
|
1
Amino acid affects EIF2AK1
|
1
Alvespimycin affects TRAF3
|
1
Alvespimycin affects JUN
|
1
Alvespimycin affects CASP1
|
1
Aluminium(3+) affects PYCARD
|
1
Aluminium(3+) affects NLRP3
|
1
Aluminium(3+) affects MYD88
|
1
Aluminium(3+) affects MAPK14
|
1
Alpha-tocopherol affects JUN
|
1
Alpha-linolenic acid affects RELA
|
1
Alpha-L-Rhap-(1->3)-[alpha-L-Rhap-(1->3)-beta-D-Glcp-(1->4)]-alpha-D-Glcp-(1->2)-alpha-D-GlcpO[CH2]5NH2 affects TLR7
|
1
All-trans-retinol affects JUN
|
1
All-trans-retinoic acid affects STAT1
|
1
All-trans-retinoic acid affects NFKB1
|
1
All-trans-retinoic acid affects MAPK8
|
1
All-trans-retinoic acid affects MAPK14
1
|
All-trans-retinoic acid affects DDX58
|
1
|
1
|
1
|
1
|
1
|
1
|
1
Aldosterone affects TBK1
|
1
Acrylamide affects NLRP3
|
1
Acridine orange free base affects IRF3
|
1
Acetylsalicylic acid affects NLRP3
|
1
Acetylsalicylic acid affects MYD88
|
1
Acetylsalicylic acid affects ITCH
|
1
Acetylsalicylic acid affects FOS
|
1
Acetylsalicylic acid affects CHUK
|
1
Acetylcholine affects RELA
|
1
Acetylcholine affects NLRP3
|
1
Acetylcholine affects NFKB1
|
1
Acetylcholine affects MAPK14
|
1
Acetohydroxamic acid affects ITCH
|
1
Acetic acid affects NFKBIA
|
1
Acetic acid affects MAVS
|
1
Acetic acid affects ITCH
|
1
Acetazolamide(1-) affects MAVS
|
1
Acetaldehyde affects NFKBIA
|
1
Acetaldehyde affects JUN
|
1
Acetaldehyde affects CASP1
|
1
Acenaphthoquinone affects CASP1
|
1
Acarbose(1+) affects NLRP3
|
1
1
|
[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE affects MAPK14
1
|
[4-[[4-(1-benzothiophen-2-yl)-2-pyrimidinyl]amino]phenyl]-[4-(1-pyrrolidinyl)-1-piperidinyl]methanone affects CHUK
1
|
1
|
Trp-Leu-Leu affects TRAF6
|
1
Triton X-100 affects RELA
|
1
Triptolide affects TICAM1
|
1
Triptolide affects STAT1
|
1
Triptolide affects MAP3K7
|
1
Triazolopyridine affects MAPK14
1
|
Tofacitinib affects TYK2
1
|
Tofacitinib affects JAK1
1
|
Thr-Ala-Ser affects DDX58
|
1
Tarenflurbil affects IKBKG
1
|
Talmapimod affects MAPK14
1
|
TANZISERTIB affects MAPK8
1
|
Sulfonylurea affects NLRP3
|
1
Soyasaponin A1 affects TRAF6
|
1
Solcitinib affects JAK1
1
|
Sodium salicylate affects IKBKB
1
|
Sodium salicylate affects CASP1
1
|
Sildenafil affects IFNB1
|
1
Sildenafil citrate affects NFKB1
|
1
Salvianolic acid A affects MAPK14
|
1
SILMITASERTIB affects TBK1
1
|
|
1
S-adenosyl-L-methionine affects NFKBIA
|
1
S-adenosyl-L-methioninate affects IKBKB
|
1
S-Ruxolitinib affects MAP3K7
1
|
Ro 320-1195 affects MAPK14
1
|
Ro 31-8220 affects RELA
|
1
Ro 31-8220 affects MAPK8
1
|
Rimonabant affects FOS
1
|
Rifampicin affects ITCH
|
1
Resiquimod affects TLR7
1
|
Ralimetinib affects MAPK14
1
|
RALIMETINIB affects MAPK14
1
|
RALIMETINIB MESYLATE affects MAPK14
1
|
Pyrazolanthrone affects MAPK8
1
|
Pseudoephedrine affects NFKB1
1
|
Pseudoephedrine affects JUN
1
|
Pravastatin affects NFKBIA
|
1
Pravastatin affects JUN
|
1
Pralnacasan affects CASP1
1
|
Pentoxifylline affects RELA
1
|
Pacritinib affects TYK2
1
|
Pacritinib affects JAK1
|
1
PF-03715455 affects MAPK14
1
|
PEFICITINIB affects TYK2
1
|
PEFICITINIB affects JAK1
1
|
PEFICITINIB HYDROBROMIDE affects TYK2
1
|
PEFICITINIB HYDROBROMIDE affects JAK1
1
|
PD-0166285 affects MAPK8
1
|
PD-0166285 affects MAPK14
1
|
PD 0325901 affects MAPK8
|
1
PD 0325901 affects FOS
|
1
PCID:5359476 affects IKBKB
|
1
PCID:5359476 affects CHUK
|
1
PCID:5281051 affects IFIH1
|
1
PACRITINIB affects TYK2
1
|
O-phospho-L-threonine affects RELA
|
1
Nonylphenol affects IRF7
|
1
Nonylphenol affects IFNB1
|
1
NOTHOSPONDIN affects JUN
1
|
1
|
NF-kappaB Decoy affects NFKB1
1
|
1
|
|
1
N-tert-butyl-3-[[5-methyl-2-[4-[2-(1-pyrrolidinyl)ethoxy]anilino]-4-pyrimidinyl]amino]benzenesulfonamide affects TBK1
1
|
N-tert-butyl-3-[[5-methyl-2-[4-[2-(1-pyrrolidinyl)ethoxy]anilino]-4-pyrimidinyl]amino]benzenesulfonamide affects MAPK8
1
|
N-tert-butyl-3-[[5-methyl-2-[4-[2-(1-pyrrolidinyl)ethoxy]anilino]-4-pyrimidinyl]amino]benzenesulfonamide affects IKBKE
1
|
N-tert-butyl-3-[[5-methyl-2-[4-[2-(1-pyrrolidinyl)ethoxy]anilino]-4-pyrimidinyl]amino]benzenesulfonamide affects IKBKB
1
|
N-tert-butyl-3-[[5-methyl-2-[4-[2-(1-pyrrolidinyl)ethoxy]anilino]-4-pyrimidinyl]amino]benzenesulfonamide affects CHUK
1
|
N-nitrosodiethylamine affects STING1
|
1
N-nitrosodiethylamine affects STAT1
|
1
N-nitrosodiethylamine affects MAPK8
|
1
N-nitrosodiethylamine affects IRF3
|
1
N-nitrosodiethylamine affects IKBKB
|
1
N-methyl-N-[3-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]-2-pyridinyl]methanesulfonamide affects TYK2
1
|
N-methyl-D-aspartic acid affects TRIM25
|
1
N-methyl-D-aspartic acid affects NFKBIA
|
1
N-methyl-D-aspartic acid affects NFKB1
|
1
N-methyl-D-aspartic acid affects JUN
|
1
N-methyl-4-phenylpyridinium affects RELA
1
|
N-hexadecanoylsphingosine affects NFKBIA
|
1
|
1
N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide affects MAPK14
1
|
1
|
N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide affects MAPK14
1
|
N-cyclopropyl-3-\{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydropyrazolo[3,4-b]pyridin-4-yl]amino\}-4-methylbenzamide affects MAPK14
1
|
|
1
|
1
|
1
N-acetylsphingosine affects FOS
|
1
N-acetyl-beta-neuraminic acid affects CASP1
|
1
N-acetyl-L-cysteine affects STAT1
|
1
N-acetyl-L-cysteine affects ITCH
|
1
N-acetyl-L-cysteine affects CHUK
1
|
N-acetyl-L-cysteinate affects TRAF6
|
1
N-acetyl-L-cysteinate affects IKBKB
|
1
N-acetyl-L-cysteinate affects CASP1
|
1
N-\{5-chloro-4-[(4-chlorophenyl)(cyano)methyl]-2-methylphenyl\}-2-hydroxy-3,5-diiodobenzamide affects MAPK14
1
|
1
|
N-[3-[[5-iodo-4-[3-[[oxo(thiophen-2-yl)methyl]amino]propylamino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide affects TANK
|
1
N-[3-[[5-bromo-4-[2-(1H-imidazol-5-yl)ethylamino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide affects TYK2
1
|
|
1
N-[2-methyl-5-[[[3-(4-methyl-1-imidazolyl)-5-(trifluoromethyl)phenyl]-oxomethyl]amino]phenyl]-5-isoxazolecarboxamide affects MAPK14
1
|
N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide affects MAPK14
1
|
|
1
|
1
|
1
N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-n-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-amine affects JAK1
1
|
|
1
Meriolin 2 affects MAP3K7
1
|
Meriolin 2 affects IKBKB
1
|
Meriolin 2 affects CHUK
1
|
Manumycin A affects CHUK
|
1
MOMELOTINIB DIHYDROCHLORIDE affects CHUK
1
|
Leu-Val-Ser affects RELA
|
1
Leu-Val-Ser affects NFKBIA
|
1
Leu-Val-Ser affects CASP1
|
1
LY-2157299 affects MAPK14
1
|
LPS with O-antigen affects TRAF6
|
1
LPS with O-antigen affects TRAF3
|
1
LPS with O-antigen affects NLRP3
|
1
LPS with O-antigen affects NFKBIA
|
1
LPS with O-antigen affects MAP3K7
|
1
LPS with O-antigen affects IFNB1
|
1
LPS with O-antigen affects CASP1
|
1
L-prolylglycine affects RELA
|
1
L-prolylglycine affects NLRP3
|
1
L-prolino group affects MAVS
|
1
L-prolino group affects DDX58
|
1
L-kynurenine affects TRAF6
|
1
L-glutamine affects ITCH
|
1
L-glutamine affects IKBKB
|
1
L-glutamine affects IFNB1
|
1
L-glutamic acid affects RELA
|
1
L-dehydroascorbic acid affects IKBKB
|
1
L-cysteine affects PYCARD
|
1
L-cysteine affects NFKB1
|
1
L-ascorbic acid affects NFKB1
|
1
L-ascorbic acid affects JUN
|
1
L-ascorbic acid affects CHUK
|
1
L-arginine affects FOS
|
1
L-alanyl-L-alanine affects NFKBIA
|
1
L-alanyl-L-alanine affects IKBKB
|
1
Isatoribine affects TLR7
1
|
Interferon alfa affects IFNAR1
1
|
Ins-1-P-Cer(t18:0/2-OH-26:0) affects RELA
|
1
Ins-1-P-Cer(t18:0/2-OH-26:0) affects PYCARD
|
1
Ile(5)-angiotensin II (1-7) affects MAPK14
|
1
ILORASERTIB affects TYK2
1
|
ILORASERTIB affects IKBKE
1
|
Hesperidin affects RELA
|
1
Hemoglobin affects NFKB1
|
1
HG-9-91-01 affects MAPK8
1
|
HG-9-91-01 affects MAPK14
1
|
Guggulsterone affects NFKBIA
|
1
Guggulsterone affects MYD88
|
1
Gly-Phe zwitterion affects TRIM25
|
1
Gly-Phe zwitterion affects MYD88
|
1
Glucosamine affects NFKBIA
|
1
GSK2656157 affects EIF2AK1
1
|
GSK-994854A affects MAPK8
1
|
Fostamatinib affects TYK2
1
|
Fostamatinib affects TBK1
1
|
Fostamatinib affects RIPK1
1
|
Fostamatinib affects MAPK14
1
|
Fostamatinib affects IKBKE
1
|
Fostamatinib affects IKBKB
1
|
Fostamatinib affects EIF2AK1
1
|
Fluticasone affects TBK1
|
1
Fedratinib affects JAK1
1
|
FLAVOPYRIDOL affects EIF2AK1
1
|
FILAMINAST affects MAPK14
1
|
Ertiprotafib affects IKBKB
1
|
ERTIPROTAFIB affects IKBKB
1
|
ENTRECTINIB affects JAK1
1
|
|
1
Dizocilpine affects FOS
|
1
Dimethyl fumarate affects RELA
1
|
Delta(9)-tetrahydrocannabinol affects IFNB1
|
1
Dehydroascorbate affects PYCARD
|
1
DIHYDROGUAIARETIC ACID affects JUN
1
|
DIHYDROGUAIARETIC ACID affects FOS
1
|
D-threo-isocitric acid affects TRAF6
|
1
D-ribofuranose affects FOS
|
1
D-ribofuranose affects DDX58
|
1
D-glucopyranose affects MAPK8
1
|
D-glucitol affects NLRP3
|
1
D-glucaric acid affects IFIH1
|
1
D-aspartic acid affects RELA
|
1
D-alpha-aminobutyric acid affects MAPK14
|
1
Cysteine-S-acetamide affects OAS1
1
|
Cyclo(His-Pro) affects NLRP3
|
1
Cyanidin Chloride affects FOS
|
1
Core protein affects STAT1
|
1
Chinese gallotannin affects MAPK14
1
|
Chelidonic acid affects CASP1
|
1
CENISERTIB affects TYK2
1
|
CENISERTIB affects TBK1
1
|
CENISERTIB affects MAPK8
1
|
CENISERTIB affects IKBKE
1
|
Bardoxolone methyl affects NFKBIA
1
|
BMS-582949 affects MAPK14
1
|
BITHIONOLATE SODIUM affects MAPK14
1
|
BERKELEYAMIDE D affects CASP1
1
|
BERKELEYAMIDE A affects CASP1
1
|
B-Raf inhibitor affects JUN
|
1
Astaxanthin affects NFKBIA
1
|
Aprepitant affects ITCH
|
1
Andrographolide affects NFKB1
1
|
Aloe emodin affects STAT1
|
1
Aldosterone affects JUN
|
1
Ala-Gly-Ser affects RELA
|
1
Acetylsalicylic acid affects NFKBIA
1
|
Acetylcysteine affects IKBKB
1
|
Acetylcysteine affects CHUK
1
|
Ac-Asp-Glu-Val-Asp-H affects JUN
|
1
Abemaciclib affects CHUK
1
|
AICA ribonucleotide affects TBK1
|
1
AICA ribonucleotide affects ITCH
|
1
ABEMACICLIB affects CHUK
1
|
9H-xanthine affects RELA
|
1
9-(tetrahydrofuryl)adenine affects CASP1
|
1
|
1
7,8-dihydromonapterin affects CASP1
|
1
6alpha-methylprednisolone affects STAT1
|
1
6-aminonicotinamide affects STING1
|
1
6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one affects MAP3K7
1
|
6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one affects JAK1
|
1
6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one affects IKBKB
1
|
6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one affects CHUK
1
|
1
|
5beta-dihydrotestosterone affects RELA
|
1
5beta-dihydrotestosterone affects NFKB1
|
1
|
1
5Z-7-oxozeaenol affects STAT1
|
1
|
1
|
1
5-isoquinolinesulfonic acid [4-[(2S)-2-[5-isoquinolinylsulfonyl(methyl)amino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl]phenyl] ester affects CASP1
|
1
5-hydroxymethylfurfural affects NFKB1
|
1
5-formyluracil affects NFKBIA
|
1
5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine affects MAP3K7
1
|
5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine affects JAK1
1
|
5-chloro-4-(1H-indol-3-yl)-N-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-2-pyrimidinamine affects MAPK8
1
|
5-aminolevulinic acid affects RIPK1
|
1
5-aminolevulinic acid affects PYCARD
|
1
|
1
5-(tetradecyloxy)-2-furoic acid affects JAK1
|
1
5-(5,6-dimethoxy-1-benzimidazolyl)-3-[[2-(trifluoromethyl)phenyl]methoxy]-2-thiophenecarboxamide affects MYD88
|
1
5-(5,6-dimethoxy-1-benzimidazolyl)-3-[(2-methylsulfonylphenyl)methoxy]-2-thiophenecarbonitrile affects TBK1
1
|
|
1
4-methyl-N-[3-(morpholin-4-yl)phenyl]-3-[3-(piperidin-4-yl)-1,2-benzoxazol-6-yl]benzamide affects MAPK14
1
|
4-hydroxynon-2-enal affects RELA
1
|
4-hydroxynon-2-enal affects NFKB1
1
|
4-aminobenzoic acid affects NFKB1
|
1
4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-quinolinone affects MAP3K7
1
|
1
|
4-[[4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazol-1-yl]-oxomethyl]-2-piperazinone affects TLR7
|
1
4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(4-morpholinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-pyridinone affects TYK2
1
|
4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(4-morpholinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-pyridinone affects JAK1
1
|
1
|
4-[(7-oxo-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-ylidene)methylamino]-N-(2-pyridinyl)benzenesulfonamide affects TYK2
1
|
4-[(7-oxo-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-ylidene)methylamino]-N-(2-pyridinyl)benzenesulfonamide affects MAPK8
1
|
1
|
|
1
1
|
3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID affects CASP1
1
|
3-methylcholanthrene affects STAT1
|
1
3-methylcholanthrene affects RELA
|
1
3-methylcholanthrene affects IKBKB
|
1
3-methyladenine affects STING1
|
1
3-methyl-9H-xanthine affects STAT1
|
1
3-[[4-(dimethylamino)-1-oxobut-2-enyl]amino]-N-[4-[[4-(2-phenyl-3-pyrazolo[1,5-a]pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide affects MAPK8
1
|
|
1
|
1
|
1
1
|
1
|
1
|
1
|
3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxo-6-quinazolinyl)amino]phenyl]benzamide affects MAPK14
1
|
3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA affects MAPK14
1
|
|
1
1
|
3,5-dinitrosalicylic acid affects STAT1
|
1
3,4-dihydroxyphenylethyleneglycol affects FOS
|
1
3,4,5-trihydroxybenzoic acid [(2S,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl] ester affects STAT1
1
|
25-hydroxycholesterol affects NLRP3
|
1
24-methylidenelophenol affects STAT1
|
1
2-tert-butylhydroquinone affects NLRP3
|
1
2-hydroxyethyl methacrylate affects RELA
1
|
2-hydroxy-17beta-estradiol affects RELA
|
1
2-hydroxy-17beta-estradiol affects JUN
|
1
2-hydroxy-17beta-estradiol affects JAK1
|
1
2-hydroxy-17beta-estradiol affects IFNB1
|
1
2-hydroxy-17beta-estradiol affects FOS
|
1
2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide affects MAPK8
1
|
2-deoxy-D-glucopyranose affects RIPK1
|
1
2-cyclopenten-1-one affects RELA
|
1
2-arachidonoylglycerol affects ITCH
|
1
2-aminooctadec-4-ene-1,3-diol affects RIPK1
|
1
2-aminoethoxydiphenylborane affects PYCARD
|
1
2-aminoadipic acid affects ITCH
|
1
2-amino-6-[2-(cyclopropylmethoxy)-6-oxo-1-cyclohexa-2,4-dienylidene]-4-(4-piperidinyl)-1H-pyridine-3-carbonitrile affects IKBKB
1
|
2-amino-6-[2-(cyclopropylmethoxy)-6-oxo-1-cyclohexa-2,4-dienylidene]-4-(4-piperidinyl)-1H-pyridine-3-carbonitrile affects CHUK
1
|
2-amino-2-deoxy-D-glucopyranose affects RELA
1
|
2-amino-2-deoxy-D-glucopyranose affects NFKB1
1
|
2-amino-2-deoxy-D-glucopyranose affects CHUK
1
|
2-[[5-chloro-2-[2-methoxy-4-(4-morpholinyl)anilino]-4-pyrimidinyl]amino]-N-methylbenzamide affects MAPK8
1
|
2-[3-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-1H-pyrazol-5-yl]-N-(3-fluorophenyl)acetamide affects MAP3K7
1
|
2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1-pyrazolyl]-3-azetidinyl]acetonitrile affects STAT1
|
1
2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE affects MAPK14
1
|
|
1
2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile affects NLRP3
|
1
|
1
|
1
2,6-dimethylpyridine affects PYCARD
|
1
2,6-di-tert-butyl-4-methylphenol affects RELA
1
|
|
1
2,5-diphenylfuran affects MYD88
|
1
|
1
2,4-dinitrobenzenesulfonic acid affects NLRP3
|
1
|
1
|
1
|
1
1
|
2,3,7,8-tetrachlorodibenzodioxine affects JUN
|
1
2,2,2-trifluoroethanol affects RIPK1
|
1
1H-imidazole affects CASP1
|
1
|
1
|
1
17beta-estradiol affects NLRP3
|
1
17beta-estradiol affects JUN
|
1
17beta-estradiol affects FOS
|
1
17alpha-ethynylestradiol affects MYD88
|
1
17alpha-ethynylestradiol affects FOS
|
1
17(18)-EpETE affects NFKBIA
|
1
15-oxo-ETE affects NFKBIA
1
|
15-oxo-ETE affects IKBKB
1
|
|
1
|
1
|
1
|
1
1-phenylethanol affects CASP1
|
1
|
1
1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-2-benzimidazolamine affects MAP3K7
1
|
1-cyclopropyl-3-[3-[5-(4-morpholinylmethyl)-2-benzimidazolylidene]-1,2-dihydropyrazol-4-yl]urea affects TYK2
1
|
1-chloro-2,4-dinitrobenzene affects NFKBIA
|
1
1-[5-t-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-phenylmethoxyethyl)-1,3-thiazol-2-yl]urea affects MAPK14
1
|
1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE affects CASP1
1
|
1,4-dithiothreitol affects MAPK8
1
|
1,4-dithiothreitol affects JAK1
|
1
1,4-dithiothreitol affects IRF3
|
1
1,4-dithiothreitol affects IKBKG
|
1
1,4-dithiothreitol affects CHUK
1
|
1,4-benzoquinone affects IKBKB
|
1
1,4-benzoquinone affects CHUK
|
1
1,3,5-trinitrobenzene affects NLRP3
|
1
1,2-oxazolidine affects JUN
|
1
|
1
1,2-dichloroethane affects STAT1
|
1
1,2-dichloroethane affects RELA
|
1
|
1
(aminomethyl)phosphonic acid affects ITCH
|
1
(aminomethyl)phosphonic acid affects FOS
|
1
|
1
|
1
(S)-nicotine affects JUN
1
|
(S)-nicotine affects FOS
1
|
(S)-naringenin affects NLRP3
|
1
(S)-naringenin affects IRF3
|
1
(S)-lactic acid affects TRAF3
|
1
(S)-lactic acid affects ITCH
|
1
(R)-rosmarinic acid affects NLRP3
|
1
(R)-rosmarinic acid affects IKBKB
|
1
(R)-lipoic acid affects NFKB1
|
1
(R)-carnitine affects RELA
|
1
(E,E,E)-geranylgeraniol affects CASP1
|
1
(E)-cinnamaldehyde affects CASP1
|
1
(E)-4-hydroxynon-2-enal affects NFKBIA
|
1
(E)-4-hydroxynon-2-enal affects JUN
|
1
(E)-4-hydroxynon-2-enal affects IKBKB
|
1
(E)-4-hydroxynon-2-enal affects CASP1
|
1
(E)-3-tosylacrylonitrile affects RELA
|
1
|
1
(4S)-limonene affects JUN
|
1
(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[[(1S)-1-carboxy-2-phenylethyl]amino]-oxomethyl]-1-pyrrolidinyl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid affects MAPK8
|
1
1
|
(2R)-2-\{(1R)-1-hydroxy-15-[2-(20-methoxy-21-methylnonatriacontyl)cyclopropyl]pentadecyl\}hexacosanoic acid affects TLR7
|
1
(2R)-2-\{(1R)-1-hydroxy-15-[2-(20-methoxy-21-methylnonatriacontyl)cyclopropyl]pentadecyl\}hexacosanoic acid affects TBK1
|
1
(2R)-2-\{(1R)-1-hydroxy-15-[2-(20-methoxy-21-methylnonatriacontyl)cyclopropyl]pentadecyl\}hexacosanoic acid affects IRF3
|
1
(20S)-ginsenoside Rh1 affects JUN
1
|
(20S)-ginsenoside Rg3 affects NLRP3
|
1
(20S)-ginsenoside Rg3 affects MAP3K7
|
1
(20S)-ginsenoside Rg3 affects CASP1
|
1
(1R,2S)-tranylcypromine affects FOS
|
1
(17S)-17-[2-[4-[2,6-bis(1-pyrrolidinyl)-4-pyrimidinyl]-1-piperazinyl]-1-oxoethyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one affects CASP1
1
|
(-)-noscapine affects NFKBIA
|
1
(-)-epigallocatechin 3-gallate affects MYD88
|
1
(-)-epigallocatechin 3-gallate affects MAPK8
|
1
(-)-epigallocatechin 3-gallate affects JAK1
|
1
(-)-epigallocatechin 3-gallate affects IFIH1
|
1
(-)-epicatechin-3-O-gallate affects DDX58
|
1
(-)-DIHYDROGUAIARETICACID affects JUN
1
|
(-)-DIHYDROGUAIARETICACID affects FOS
1
|
(+)-sesamin affects MAPK14
|
1
(+)-pilocarpine affects RELA
|
1
(+)-pilocarpine affects NFKBIA
|
1
(+)-pilocarpine affects FOS
|
1
(+)-catechin affects RELA
|
1
(+)-artemisinin affects NLRP3
|
1
(+)-alpha-tocopherol affects RELA
|
1
(+)-alpha-tocopherol affects NFKBIA
|
1
(+)-alpha-tocopherol affects CHUK
|
1
(+)-Tetrandrine affects RELA
1
|
Uridine 5'-monophosphate affects STAT1
|
1
Uridine 5'-monophosphate affects IRF7
|
1
Indirubin-3'-oxime affects MAPK8
|
1
|
1
1
|
1
|
Adenosine 5'-monophosphate affects MAPK8
|
1
Adenosine 5'-monophosphate affects CHUK
|
1
N1'-[3-fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide affects TBK1
1
|
N1'-[3-fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide affects RIPK1
1
|
N1'-[3-fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide affects MAPK14
1
|
N1'-[3-fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide affects MAP3K7
1
|
N1'-[3-fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide affects EIF2AK1
1
|
1
|
1
|
N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide affects MAPK14
1
|
1
|
1
|
Bandrowski's base affects MYD88
|
1
5-aza-2'-deoxycytidine affects STING1
|
1
5-aza-2'-deoxycytidine affects NFKBIA
|
1
5,7-dihydroxy-4'-methoxyflavone affects STAT1
|
1
|
1
5'-S-methyl-5'-thioadenosine affects NFKB1
|
1
5'-S-methyl-5'-thioadenosine affects JUN
|
1
4'-epidoxorubicin affects NLRP3
|
1
3,3'-diindolylmethane affects RELA
|
1
3,3'-diaminobenzidine affects RIPK1
|
1
3,3',5-triiodo-L-thyronine affects TBK1
|
1
3,3',5,5'-tetrabromobisphenol A affects RELA
1
|
3,3',4,5'-tetrahydroxystilbene affects IKBKB
1
|
3,3',4,4',5-pentachlorobiphenyl affects RELA
|
1
3',5'-cyclic AMP affects MAVS
|
1
3',5'-cyclic AMP affects MAPK8
|
1
3',5'-cyclic AMP affects JAK1
|
1
3',5'-cyclic AMP affects IFNB1
|
1
|
1
2'-deoxyadenosine affects IFNB1
|
1
|
1
2'-O-methyluridine affects TBK1
|
1
2'-O-methyluridine affects NFKB1
|
1